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ABSTRACT

Schmitt, Paul D. Ph.D., Purdue University, August 2016. Coupling Qualitative and
Quantitative Analyses of Pharmaceutical Materials Enabled by Second Harmonic
Generation Microscopy. Major Professor: Garth J. Simpson.

The detection and characterization of crystallinity is critical throughout the drug
development process. From the initial establishment of an active pharmaceutical
ingredient’s (API) crystal structure to stability testing and quality control, the phase of an
API affects the solubility, bioavailability, stability, and efficacy of a drug product.
Second harmonic generation (SHG) microscopy has recently been developed as a
selective and rapid method for imaging crystallinity in drug formulations. While SHG
microscopy can enable the high signal-to-noise (SNR) detection of crystallinity, the
intrinsic chemical information content within SHG images is relatively low. In cases of
trace crystallinity and/ or small crystal volumes, new tools capable of rapid, qualitative
crystal characterization are needed to fill this measurement gap. Several strategies for
increasing the chemical information content of SHG microscopy were developed.
Following combined computational and experimental studies to help determine the body
of crystalline API structures amenable to imaging by SHG microscopy, measurements by
confocal Raman spectroscopy and synchrotron X-ray diffraction were performed on
regions of interest (ROI) identified by SHG. In both cases, spatial restriction of the
spectroscopic technique to these regions of interest lowered the detection limits of Raman
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and synchrotron X-ray diffraction by several orders of magnitude. To further expand the
capabilities of SHG microscopy, nonlinear optical Stokes ellipsometric (NOSE)
microscopy was developed to assess crystal structure characteristics through the
polarization dependence of SHG. Rapid (8 MHz) polarization modulation enabled NOSE
microscopies at video rates (up to 15 Hz). Following development and validation, NOSE
microscopy was used in conjunction with an iterative, nonlinear least-squares fitting
algorithm to discriminate polymorphic crystal forms of the small molecule D-mannitol.
Finally, to extend the linear dynamic range of photon counting measurements as
described here-in, a novel digital filter derived from linear discriminant analysis (LDA)
was developed and validated via theoretical and experimental nonlinear optical (NLO)
measurements.
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CHAPTER 1. INTRODUCTION

1.1 Background and Motivation
An increasingly large percentage of emerging active pharmaceutical ingredients
(APIs) experience significant formulations challenges due to low bioavailability
stemming from poor aqueous solubility.1,2 It is estimated that 70-90% of new chemical
entities (NCEs) under development are in danger of being abandoned as therapeutic
molecules.3,4 The advent of solid dispersions, in which the API is cast in an amorphous
state within a polymer matrix, has been shown to be an effective strategy for increasing
the aqueous dissolution kinetics of such APIs.5,6 Unfortunately, this increase in solubility
is primarily contributable to an increase in product free energy. Such amorphous
formulations are thus in danger of crystallizing over time, leading to a compromise of
formulation stability, shelf-life, and ultimately therapeutic effect.7 Thorough knowledge
of any trace crystalline content and polymorphic crystalline form of an API within an
amorphous formulation is paramount to ensuring proper therapeutic effects.

1.2 Past Efforts in Pharmaceutical Crystal Analysis
Second harmonic generation (SHG) microscopy has recently been demonstrated
as a fast, selective, and sensitive technique for imaging trace crystallinity within bulk
amorphous materials and API final dosage forms.8–10 Crystalline detection limits for SHG

2
microscopy are on the order of parts per billion (ppb),9 demonstrating a significant
decrease from the ~1% detection limits of orthogonal techniques such as powder X-ray
diffraction (PXRD), Raman/ IR spectroscopies, differential scanning calorimetry (DSC),
and solid state NMR (ssNMR), among others.11–18 The ability to detect low (<1%) levels
of crystallinity is important for characterizing trace crystallinity in amorphous
formulations, particularly for final dosage forms at low (5-10% w/w) overall drug
loadings (DLs). Even in the case of complete API crystallization at these low DLs, the
total crystalline content may approach the limits of detection of these common analysis
techniques. Partial crystallization of low DL formulations presents further measurement
challenges, as the total mass fraction of crystalline API may approach that of other
impurities within the product. Knowledge of crystal identity and polymorphic form
within such formulations is thus critical to ensuring drug stability, solubility and proper
therapeutic function. While SHG microscopy has been shown to be a powerful technique
for the detection and quantification of trace crystallinity, the inherent chemical
information content of SHG is intrinsically low. The bulk selection rule for SHG merely
requires materials that are noncentrosymmetric, and little to no spectral information is
probed in the course of the measurement. Accordingly, confirmation of crystal chemical
identity and lattice structure is difficult to perform by SHG microscopy alone. New
analysis tools enabling rapid, qualitative characterization of trace crystallinity are needed
to address these measurement challenges.
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1.3 Thesis Overview
Crystal analysis based on SHG microscopy has the potential to reduce bottlenecks
in many stages of the drug development pipeline. To first assess the potential
compatibility of a variety of APIs with analysis by SHG, a model for predicting the
relative SHG activities of emerging drug molecules was developed and compared to
experimental results. Time-dependent Hartree-Fock calculations were first performed for
the molecular building block (i.e., the API), with subsequent application of an analytical
model describing the symmetry of the crystal lattice. Trends of relative SHG activity for
18 common APIs generally agreed well with experimental results, with outliers primarily
attributed to the presence of trace quantities of unanticipated, metastable SHG-active
crystal forms present in the commercial powder. These results demonstrate both the
broad utility of API crystal analysis by SHG, as well as the ability of relatively simple
models to predict SHG activity ab initio.
Due to the relatively high detection limits (~1%) of common crystal analysis
techniques (PXRD, Raman), the trace levels of crystallinity potentially found in
amorphous formulations present measurement challenges for characterizing not only the
overall crystalline content, but also crystal chemical identity and structure. Coupling
SHG to these orthogonal techniques can enable analysis of trace crystallinity well-below
the detection limits of spectral measurements taken alone. SHG-guided Raman
spectroscopy was used for the analysis of the commercial amorphous anti-cancer
formulation Abraxane (nanoparticle albumin-bound paclitaxel). SHG indicated the
presence of trace-crystalline domains within the powdered sample. Raman spectra of the
SHG-active domains were consistent with Raman spectra of pure crystalline paclitaxel.
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Coupling these two approaches enabled chemical characterization of regions of interest
identified by SHG while simultaneously reducing the time required for characterization
by Raman spectroscopy through informed beam placement. Similarly, SHG-guided
synchrotron X-ray diffraction (XRD) was used to characterize crystal identity and lattice
structure in a trace (100 ppm) physical mixture of crystalline ritonavir (RTV) in the
common excipient hydroxypropyl methylcellulose (HPMC). A combined microscope
integrating SHG into a synchrotron beam line (23-ID-B, Advanced Photon Source,
Argonne National Laboratory) enabled diffraction measurements from a 5 m
synchrotron beam selectively targeted to regions of interest identified by SHG. Observed
diffraction patterns were indexed and agreed well with theoretical diffraction patterns for
RTV. These combined measurements lower the detection limits of synchrotron XRD into
the ppm regime while simultaneously validating ppm-level crystal detection by SHG
microscopy.
In addition to coupling SHG to orthogonal methods such as Raman and XRD,
new instrumentation enabling rapid polarization modulation in SHG microscopy also has
the potential to probe structural properties of crystals. As the symmetry properties and
orientation of the crystal lattice affect the relative SHG efficiency for given incident
polarizations, modulation of the driving electric field and measurement of the
polarization state of the second harmonic can be used to probe structural properties of the
crystal. Rapid (8 MHz) polarization was performed with an electro-optic modulator
(EOM), enabling polarization-modulated SHG imaging at video rates. Following initial
validation of the instrumentation using Z-cut quartz, polarization-modulated SHG
microscopy was used to discriminate two polymorphic crystalline forms of the small
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molecule D-mannitol. Discrimination was optimized when the orientational effects were
removed from the polarization-dependent response via a novel iterative, nonlinear leastsquares fitting algorithm. Discrimination of orthorhombic and monoclinic crystal forms
was achieved within the 99.99% confidence interval.
Finally, post-data acquisition strategies to increase the signal to noise ratio (SNR)
of nonlinear optical (NLO) images have the potential to benefit this collective set of
measurements. For imaging based on photon counting, the upper limit on the linear
dynamic range (LDR) of the measurement is severely restricted due to temporal pulse
pile-up in the raw voltage transients emerging from the photomultiplier tube (PMT).
Digital strategies to increase this LDR enable higher accuracy in quantitative NLO
measurements. A novel digital filter derived from linear discriminant analysis (LDA) was
developed and found to improve the LDR of photon-counting measurements by
approximately 3 orders of magnitude. The digital filter is derived from a 2-class
discrimination, in which time-coincident and non-coincident voltage transients form the
two populations to be discriminated. The digital filter was also applied to experimental
two-photon excited UV fluorescence (TPE-UVF) images of crystalline tryptophan, and
was able to remove the effects of ringing in the temporal instrument response function
(IRF).
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CHAPTER 2. AB INITIO PREDICTION OF THE DIVERSITY OF SECOND
HARMONIC GENERATION FROM PHARMACEUTICALLY RELEVANT
MATERIALS

2.1 Introduction
The physical and chemical properties of active pharmaceutical ingredients (APIs)
are highly dependent on the crystal form. Currently, many techniques are used to detect
and understand crystallinity and polymorphism throughout the drug development process.
During initial development, visual inspection, polarized light microscopy, thermal
microscopy, differential scanning calorimetry (DSC), Raman spectroscopy, and X-ray
diffraction (XRD) can be used to assess the results of multi-well plate crystallization
experiments.1–6 While the sample matrix generally lacks competing materials (no buffer
salts, etc.) that would interfere with drug crystal detection, assessment of plates by these
techniques often requires several hours of measurement per plate due to long signal
integration times, as is often the case with Raman spectroscopy and XRD. The same
limitations are found later in the pipeline, where the presence of various excipients and/or
turbid matrices requires extensive signal averaging. Here again the detection of trace
crystallinity is of utmost importance, as amorphous and co-crystal formulations are
increasingly being used to enhance the bioavailability of poorly water-soluble drugs.7–10
Second harmonic generation (SHG) microscopy has recently emerged as a
complementary tool for the detection and analysis of chiral crystals.11 The symmetry-
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properties of SHG enable the selective detection of chiral crystal formation within
amorphous media with detection limits many orders of magnitude lower than alternative
bench-top methods.12–14 Potential applications of SHG imaging include initial highthroughput screening of crystallization conditions and optimization of amorphous
formulations. However, the inherent SHG activity of APIs can span many decades and be
highly dependent on the crystal lattice structure, such that different molecules can exhibit
large inherent disparities in intrinsic SHG activity, and the same target molecule can
exhibit radically different SHG activities in different crystal polymorphic forms. This
diversity in activity can challenge the design of experiments to assess likely compatibility
of target molecules and crystals with SHG analysis. A need has emerged for the
development of reliable methods for ab initio prediction of the anticipated SHG activity
of crystal forms to aid in both initial assessment of target compatibility and polymorph
analysis.
The primary goal of the present study is to quantitatively assess the merits of a
weak-coupled oscillator model for the ab initio prediction of the SHG activities of API
crystal forms. In brief, the SHG activities of crystals are predicted based on the calculated
molecular hyperpolarizabilities and the symmetry properties of the lattice in the limit of
negligible perturbation from intermolecular electronic interactions. Converting from the
molecular hyperpolarizability to the material susceptibility is achieved based on the bulk
number density of chromophores,15 which was evaluated based on the known lattice
constants of the crystals. The SHG intensities of the powder are then calculated using the
isotropic invariants in expressions describing hyper-Rayleigh scattering.16 Pure
crystalline powders of these same and additional APIs and excipients were then analyzed
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experimentally for their observed SHG response, with sample preparation methodology
similar to that of Kurtz-Perry.17–20

2.2 Materials and Methods
All calculations were done using the General Atomic and Molecular Structure
System (GAMESS) quantum chemical package.21 Each hyperpolarizability calculation
was performed using time-dependent Hartree Fock (TDHF) using a restricted Hartree
Fock self-consistent field with a 6-311G basis set including d and p heavy atom
polarization functions and diffuse L-shell on heavy atoms. The incident energy for all
calculations was chosen to be 0.043 Hartrees, corresponding to the 1060 nm incident
beam used in the experiments. Unmodified atomic geometry coordinates were obtained
from the Cambridge Structural Database (CSD). Avogadro software,22 version 1.0.3, was
used to convert the files to GAMESS input cards. Chimera NLOPredict was used for the
tensor evaluations and visualizations.23 Calculations were performed on the following
molecules with TDHF: benzocaine (QQQAXG05), captopril (MCPRPL), clarithromycin
(NAVSUY), D-(-)-salicin (CIZWOX), dexamethasone (DEXMET11), efavirenz
(AJEYAQ02), flutamide (WEZCOT), griseofulvin (GRISFL03), itraconazole (TEHZIP),
ketoconazole (KCONAZ), loratadine, mevastatin (COMPAC), naproxen (COYRUD12),
quinidine (BOMDUC), tacrolimus (XAVZIF), tadalafil (IQUMAI), tolazamide
(CABCUD01), and triamcinolone (QETZUL). In the event of multiple entries in the
CSD, the structure chosen for calculations was the most recent deposit of the correct
polymorphic form. All quantum chemical calculations indicated the absence of
resonances within the visible spectrum, with the lowest electronic resonances lying in the
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ultraviolet regime. Furthermore, visual inspection indicated each sample to be a white
powder, consistent with the absence of resonances in the visible portion of the spectrum
and consistent with expectations of the quantum chemical calculations.
From the molecular β(2) tensors, the (2) tensors of the crystals were estimated by
performing the symmetry operations of the lattice as described previously and accounting
for the lattice volume.24,25 In both studies, the bulk crystal NLO properties were
approximated by averaging the orientations of the individual molecular tensors and then
taking their coherent sum. The “symmetry additive” approach used in the present study
neglects perturbations to the electronic properties of the materials from intermolecular
coupling. In general, intermolecular interactions will result in splitting to form exciton
states that ultimately result in a band structure in a lattice. While such effects can have a
profound impact on the nonlinear optical response close to resonance, it has been shown
previously by quantum chemical methods that the perturbations are only significant close
to resonance with the accuracy of the simple symmetry-additive model retained in
measurements performed far from resonance.26,27 These theoretical trends are supported
by experimental measurements in proteins, in which the intramolecular coupling from
strong chromophores28 and amide groups29 is likely to be significantly greater than
intermolecular interactions between APIs within a crystal. A graphical illustration of this
process is shown in Figure 1 for the P212121 lattice of captopril. In this case three
orthogonal

rotations were performed about the three principal axes. Although the

symmetry operations formally correspond to combinations of both rotation and
translation, the translation distance is much less than the wavelength of light and can
reasonably be neglected in the analysis. Each individual panel is a visual hyper-ellipsoid
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representation of the molecular (2) tensor, the length of which corresponds to the
magnitude of the zzz projection along that direction in space and the color of which
indicates the sign of the emerging field (red = negative, blue = positive).30 Coherent
summation of the four different captopril orientations present within the lattice leads to
the net response indicated to the right in the figure. In addition to the hyper-ellipsoid
representation, a complementary vector-sphere representation is also shown. Whereas the
hyper-ellipsoid only indicates the projection onto the normal of the sphere, the vectorsphere, or unit sphere, recovers the polarization direction of the nonlinear field and is
therefore a more complete map.31 Finally, the tensor was then scaled based on crystal
packing density by simply dividing by the unit volume to produce the crystal (2)
susceptibility. In the case of structures with Z' > 1, the summed responses of the
asymmetric units within the unit cell were calculated. First, calculations were performed
for one of the molecules in the asymmetric unit. As the conformational differences
between the unique monomers were all quite subtle, the tensor for the other unique
monomers was generated by reorientation of the molecule using NLOPredict.23 The
hyperpolarizability for each asymmetric unit was then coherently summed prior to the
calculation of the bulk crystal susceptibility based on the symmetry operations of the
lattice.
The anticipated intensity of the crystalline powder was calculated based on the
assumption of statistical sampling of equally probable crystal orientations and sizes.
Incoherent addition of signals from the many independent random sources becomes
mathematically equivalent to hyper-Rayleigh scattering. Using the isotropic invariants
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described by Bersohn et al.,16 the integrated SHG detected in the direction co-axial with
the beam propagation was used in the predicted intensities.
The instrument utilized for sample analysis is a commercially-available
Formulatrix SONICC system powered by a Fianium FemtoPower laser, 1060 nm,
capable of producing 1.3 W, 51 MHz repetition rate, and a 166 fs pulse width. Multiple
models of this instrument are available, with various detector configurations. The model
utilized in this study collected SHG light in the transmission direction, and two-photon
excited UV fluorescence (TPE-UVF) light in the reflected (epi) direction, with the latter
generated by passing the 1060 nm light through a lithium triborate doubling crystal prior
to the sample, generating 530 nm light. While theoretical TPE-UVF activities were not
calculated, the collection of TPE-UVF data was prudent for several reasons, including:
aiding in the analysis of outliers, experimental demonstration of an equally large dynamic
range for TPE-UVF, and the relative ease of obtaining additional data given the
automation of the measurements on the commercial platform.
Sample preparation can significantly influence the degree of scattering of both the
incident laser and the signal that is generated. The samples were sieved resulting in a
particle size range between 106-250 µm (tacrolimus and tadalafil were not sieved due to
limited sample quantity and cost constraints). Once sieved, the powdered samples were
placed between two glass cover slips and filled to the tops of binder reinforcement rings,
allowing for uniform sample thickness (~150 µm),. Four replicates of each sample were
prepared, and within each sample, three spots were examined for a total of 12 replicate
measurements per API. Due to the variability of sample and sample-holder positioning, a

13
1 mm distance in the z-direction (parallel to beam propagation) was probed in 40 µm
steps to ensure the entire sample was imaged.
Due to the inherent variability in both the SHG and fluorescence activities of
APIs, multiple acquisition profiles were necessary to remain within the linear dynamic
range of the photon counting hardware used. The incident laser powers at the sample
along with acquisition times are listed in Table 1 for each unique acquisition profile. The
instrument utilizes beam-scanning at ~8 kHz, allowing for higher incident laser powers
while also mitigating sample damage. All measurements were performed with a fastscanning approach designed to reduce sample perturbations from the optical beam. Each
focal volume was sampled for <125 ns per passage of the beam with ~125 µs allowed for
heat dissipation prior to resampling. Furthermore, resampling was performed no more
than 60 times per focal volume (corresponding to a ~2 s image integration time), for a
total exposure of less than 2 µs in any given focal volume. Furthermore, all
measurements were performed with an incident wavelength of 1060 nm and a
corresponding doubled wavelength 530 nm to avoid electronic resonances and absorption
at the fundamental or second harmonic frequencies. The laser was focused onto the
sample with a pseudo-10x objective providing a 500 x 500 µm field of view,
corresponding to 512 8-bit pixels on each axis.
Each field of view for the data collected was averaged and stacked (NIH
ImageJ).32 The z-plane for each sample corresponding to the greatest signal intensity was
averaged with two z-planes above and below. An average signal intensity for each API
was generated by averaging all 12 replicates. Also reported are the 95% confidence
intervals.
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2.3 Results and Discussion
A comparison of the predicted and measured SHG activities of 18 representative
APIs is shown in Figure 2. The experimentally-determined SHG activity spanned a range
of 7 decades, from loratadine (dimmest) to flutamide (brightest). All results were
normalized to the experimentally observed signal generated by flutamide, as it was
observed to have the highest SHG activity, and relative values are expressed. In general,
good agreement was found between the predicted and observed SHG activities of the
different APIs. In most instances, the ab initio calculations with no adjustable parameters
were within an order of magnitude of the experimental observations from relatively
complex mixtures of powders. Given the many factors that affect the observed SHG
activity and the relative simplicity of the analytical model, the recovery of such good
agreement across 7 decades of variation in signal is especially encouraging.
The agreement between theoretical predictions and experimental trends may
initially be surprising given the established importance of phase-matching in powders
analysis by SHG and the absence of its consideration in the simple symmetry-additive
model used. In conventional SHG powders analysis based on approaches initially
forwarded by Kurtz and Perry and subsequent refinements thereof,17–20 the measured
SHG activities recorded with a collimated or gently focused lens can vary by several
orders of magnitude for phase-matchable versus nonphase-matchable materials. Phase
matching arises when the effects of dispersion are countered by birefringence, such that
some orientations of the crystal lattice produce identical refractive indices at both the
fundamental and doubled frequencies, resulting in a semi-infinite forward coherence
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length. In the presence of phase-matching, a substantial enhancement in the SHG activity
is generated as the mean crystal size is increased.
In order to minimize potential artifacts from phase-matching effects that would
not be recovered by the quantum chemical modeling approach used, all measurements
were performed using a 10x microscope objective with a depth of field of 20 m. Typical
nonphase-matchable forward coherence lengths in APIs considering just dispersion alone
are on the order of ~5-10 µm,13 which is comparable to the depth of field. Under these
conditions, the neglect of phase-matching could result in an error in the analysis of
approximately an order of magnitude [i.e., ~(20µm/7µm)2]. In this case, the measured
SHG activities of phase-matchable materials would be significantly larger than predicted
based on the model.
Although in principle, this error from the neglect of phase-matching could be
further reduced by using an objective with an even higher numerical aperture and
narrower depth of field, the resulting field of view is also greatly reduced resulting in
potential errors from limited sampling. Even with the 10x objective, results from many
fields of view were pooled in each assessment of the crystal response in order to reduce
bias from non-representative sampling. The decision on the magnification and numerical
aperture of the objective was one based on the balance between these two potential
measurement artifacts
Experimental data for the same API provided in Figure 1 (captopril) is provided
in Figure 3. The brightfield, SHG, and TPE-UVF images are shown in Figures 3a, 3b,
and 3c, respectively. The field of view for all three images is 500 x 500 m. A 3D
rendered threshold image utilizing multiple z-planes and NIH ImageJ was utilized to

16
generate Figure 3d. A line trace is provided in Figure 3e, showing the SHG intensity
across the horizontal axis of Figure 3b (SHG image).
The ketoconazole, efavirenz, and itraconazole samples were all racemates with
centrosymmetric lattices (confirmed by the manufacturer), with the theoretical response
therefore simply set to the dark noise limit of the instrument. However, the experimental
results produced relatively weak but clearly detectable localized SHG. Closer inspection
of the images for these three compounds suggests the presence of SHG-active puncta
corresponding to a small volume fraction of noncentrosymmetric material present. The
sparse but nonzero SHG activity is tentatively attributed to the presence of trace
noncentrosymmetric crystals present within the mixture. Recent studies of metastable
homochiral crystallization from racemic solutions supports the relative ease with which
such unfavored crystal forms can be routinely produced.33 This argument is further
supported by the much weaker SHG response observed from crystals of the achiral
molecule loratadine, which occupies a centrosymmetric C2c space group and has no
viable pathway to produce metastable homochiral crystal forms. Measurements for
loratadine, which forms a centrosymmetric and SHG-inactive lattice, were also included
to indicate the lower noise-floor limits of the instrument. In addition, it is possible that
the puncta may potentially arise from racemic co-crystals adopting noncentrosymmetric
lattices. Certainly, there is established literature on this topic for achiral molecular
crystals.34–36 However, no precedent for such an occurrence could be found in a review of
the literature for racemic co-crystals.
A range of measured SHG and TPE-UVF activities for diverse representative
APIs and select excipients is provided in Figure 4. This expanded list helps place the
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APIs used for quantum chemical calculations within the scope of the broader set of
anticipated SHG activities. It is interesting to note that the diversity in SHG activities
spanning ~7 decades is roughly comparable to the span of signals observed using TPEUVF. Furthermore, little correlation between the two signals was observed, as the two
processes arise from fundamentally different physical effects. This independence is easily
illustrated by the different behaviors between griseofulvin (bright for both methods) and
flutamide (among the brightest for SHG and weakest for TPE-UVF).
It is well known that APIs have the propensity to crystallize into different
polymorphs, resulting in dramatically different physical properties. In addition to a
variation in solid-state characteristics, the generated SHG signal intensity depends on the
SHG activity of the molecule as well as how the molecule arranges itself within the
crystal lattice. The packing variability of different polymorphs can enhance or reduce the
generated SHG response. The theoretical and experimental effects of molecular packing
on SHG response has not yet been characterized in detail, but is material for future
research.

2.4 Conclusions
Reasonable agreement between the measured SHG activities and those predicted
based on ab initio TDHF calculations was observed for several representative APIs. The
seven-decade measured dynamic range of SHG activities observed for different APIs can
complicate a priori prediction of the appropriateness of a target for SHG analysis and/or
the selection of instrument setting consistent with the anticipated signal levels. This
computational framework can provide a starting point for initially estimating the
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anticipated SHG activities of small molecule crystals based on known or assumed crystal
structures. Experimental outliers in which signals above predictions were observed in
racemic solids from unanticipated SHG-active domains are tentatively attributed to
homochiral metastable crystal forms. The reasonably good overall agreement between
theory and experiment generally suggest the validity of the computational approach,
while also providing a fairly straightforward strategy for estimating the anticipated SHGactivities of new small-molecule candidate crystals.
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Table 2.1 Incident laser powers and integration times used to ensure SHG photon counts
remained within the linear dynamic range of the SONICC system.
SHG

Fluorescence

449 mw, 1.8 s

260 mW, 0.45 s

250 mw, 1.8 s

150 mW, 0.45 s

150 mW, 0.45 s

50 mW, 0.45 s

74 mW, 0.45 s

25 mW, 0.45 s
5 mW, 0.45 s
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Figure 2.1 Hyperellipsoid representation of the β tensor. The tensor magnitude for
each individual panel was scaled down by a factor of 15 relative to the sum on the right
for clarity.
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Figure 2.2 Comparison between theory and experiment for unit cell SHG activities for
known structures. The dotted line on the diagonal is shown to visualize perfect agreement
between experiment and theory. *Denotes a centrosymmetric crystalline space group,
**denotes a racemic crystalline form.
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Figure 2.3 A) Brightfield B) SHG and C) TPE-UVF images of captopril. D) 3D rendering
of the SHG image in B).E) signal profile from a line scan of the SHG image, indicated by
the red line in B).
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Figure 2.4 Summary of experimental SHG and TPE-UVF activities for a variety of
pharmaceutical materials. A) Observed relative SHG activities of all 42 compounds
studied. Compounds are listed in order of decreasing SHG activity, with dashed bars
denoting compounds for which TDHF was performed. B) Observed relative TPE-UVF
activities of the same compounds.
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CHAPTER 3. FINDING THE NEEDLE IN THE HAYSTACK:
CHARACTERIZATION OF TRACE CRYSTALLINITY IN A COMMERCIAL
FORMULATION OF PACLITAXEL PROTEIN-BOUND PARTICLES BY RAMAN
SPECTROSCOPY ENABLED BY SECOND HARMONIC GENERATION
MICROSCOPY

3.1 Introduction
Modern drug discovery frequently identifies active pharmaceutical ingredients
(APIs) that are highly effective against the disease target, but which are hard to deliver to
the biomedical target. Increasingly, new compounds exhibit low aqueous solubility,
whereby it is estimated that some 40% of new chemical entities are discarded for this
reason.1 Many solubilization strategies are designed to address this issue. One of the most
common methods towards this end is the preparation of amorphous formulations, in
which the API is molecularly dispersed in a non-crystalline highly soluble matrix to
increase the dissolution rate and transient concentration.2–10 Unfortunately, most such
formulations are inherently metastable and run the risk of spontaneously transitioning to
their more thermodynamically stable crystalline form. If such phase changes occur either
in the formulation preparation or during storage, significant reductions in drug
bioavailability may arise.
For intravenous (IV) formulations, incomplete solubilization of the API
introduces additional embolism risks associated with blood vessel occlusion by
circulation of poorly soluble API particulates. Therefore, various different strategies to
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solubilize APIs are employed, including pH adjustment and/ or the use of cosolvents,
surfactants, or emulsifiers.11–13 Unfortunately, additives used to solubilize drugs for IV
formulations can exhibit toxicity,14,15 in some cases fatal.16 Therefore, solubilization
strategies that minimize the use of additives with undesirable side-effects are of great
interest. Recently, nanosuspensions17–20 such as nanoparticle albumin-bound (NAB)
paclitaxel16 have been found to offer a potentially promising solution to this problem.
NAB paclitaxel (PTX) is manufactured through co-precipitation with human serum
albumin (HSA), leading to an amorphous formulation.16 Upon reconstitution, this
formulation is a nanosuspension containing particles ca. 120 nm in diameter.
Quantification and detection of crystallinity at low levels within such an
amorphous formulation is often a defining measurement for predicting the long-term
success of the product. For IV formulations in particular, crystal formation is detrimental
because it not only reduces the solubility advantage of the amorphous formulation, but
the presence of large, insoluble particulates is problematic and hence subject to stringent
regulations.13,21,22 Unfortunately, for potent APIs at low loadings, accurate determination
of crystallinity poses a significant measurement challenge. As the drug loading
approaches the detection limits of conventional bench top methods, even major
differences in relative drug crystallinity become difficult to distinguish with statistical
confidence. Commonly used methods for crystal detection and characterization in the
drug formulation pipeline include X-ray powder diffraction (PXRD), differential
scanning calorimetry (DSC),23 Raman spectroscopy,24,25 scanning electron microscopy
(SEM),26,27 hot stage microscopy,28 and solid-state nuclear magnetic resonance
spectroscopy (SSNMR).29 However, most of these techniques do not typically exhibit

29
detection limits for crystallinity significantly lower than ~1%, in most cases because of
background noise from the much larger non-crystalline fraction. Additionally, the
composition of NAB PTX makes assessment by several of these methods problematic.
The use of HSA as the formulation matrix would make detection of crystallinity by DSC
difficult due to the low denaturation temperature of the protein matrix. While SEM has
been used in accelerated stability studies of amorphous formulations,26,27 several
limitations complicate its application toward the analysis of bulk NAB PTX. As a surface
characterization tool, the use of SEM for monitoring crystallization is generally limited to
crystallization events taking place on the formulation’s exterior or within a thin film,
making characterization of a powdered, bulk material more difficult.
With detection limits for crystallinity approximately an order-of-magnitude lower
than mentioned above, SSNMR has been used to quantify and characterize crystalline
content within a variety of powdered samples.30–33 SSNMR characterization of NAB PTX
was previously performed in the course of patent litigation (Elan Pharma International
Ltd. v. Abraxis BioScience Inc., United States District Court for the District of Delaware)
in 2008.34,35
Nonlinear optical (NLO) microscopy, in particular second harmonic generation
(SHG), has recently emerged as a complementary technique for the rapid detection and
quantification of trace crystallinity within pharmaceutical materials.36–41 Coherent SHG
selectively arises exclusively from the bulk crystalline fraction and only within crystals of
appropriate symmetry. The chirality inherent in most new pharmaceutical APIs largely
guarantees that the crystals produced will be bulk-allowed for SHG. This selectivity for
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crystalline API has allowed measurements with detection limits on the order of parts per
billion to as low as parts per trillion ranges under favorable conditions.42
Despite the low detection limits of SHG microscopy, the SHG intensity itself
provides little significant chemical information about the composition of the SHG-active
source. In the present study, efforts were undertaken to lower the detection limits of
Raman spectroscopy through targeted analysis guided by SHG imaging. In brief,
targeting Raman analysis to regions of interest pre-identified by SHG minimizes the
volume of additional material that must be probed in conventional chemical imaging
modalities.
In the present study, assessment of this SHG-guided analysis approach was
performed for the amorphous IV formulation Abraxane® (nanoparticle albumin bound
paclitaxel for injectable suspension). Abraxane® was the first nanosuspension approved
for clinical use13,16 and is indicated to contain 10% (w/w) paclitaxel (PTX) bound to
nanoparticles of human serum albumin (HSA). Abraxane® has been shown to have
increased efficacy compared to other PTX formulations (e.g., Taxol®), particularly in the
treatment of breast cancer,16,43,44 non-small cell lung cancer,45–48 and pancreatic
carcinoma.49 PTX is generally regarded as exhibiting substantial solubility limitations,
with crystalline PTX exhibiting poor bioavailability.13 In addition to the increased
apparent solubility arising from an amorphous nanosuspension, it is thought that
Abraxane® achieves higher treatment specificity as a result of its HSA matrix, utilizing
the known high protein uptake rate of tumors.20,50–52
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3.2 Materials and Methods
Abraxane® samples were analyzed in their native (solid) form as obtained from
the manufacturer. Four different batches were imaged (lot numbers: 6106359, 6106934,
6107014, and 6107321, batches 1-4 respectively). SHG images were acquired with a
commercial SONICC (second-order nonlinear optical imaging of chiral crystals)
microscope (Formulatrix, Inc.). The system contains a Fianium FemtoPower laser (1060
nm, 1.3 W power output), with a 51 MHz repetition rate and a 166 fs pulse width. The
instrument uses resonant mirror/ galvanometer beam scanning (8 kHz fast axis) to
generate images. Unless otherwise stated, all SONICC images were acquired with 250
mW infrared (IR) power at the sample, with a 2 second image acquisition time. SHG
light was collected in the transmission direction, requiring the preparation of thin samples
to minimize scattering losses. In brief, samples were prepared by placing a small aliquot
of powder between two glass coverslips, within a thin (~100 m) spacer to ensure
uniform sample thickness.53 12 fields of view were obtained for each sample and used to
generate particle histograms. The fraction imaged by SHG represents approximately 1%
of the 1 g bulk sample, and a total volume probed of 2.2 mm3 (12 fields of view with
dimensions of 1925 m x 1925 m x 50 m). For analysis of relative PTX crystallinity in
batch 1, physical mixtures of crystalline PTX in HSA (Attix Pharmaceuticals) (0.1% 5% drug loading) were prepared as standards for a calibration curve. Given the 10%
(w/w) loading of PTX in Abraxane®, these standards correspond to 1% - 50% relative
crystallinity of the PTX. While it is possible the PTX used to create the calibration curve
standards differs in crystal form from the PTX present within Abraxane®, the two most
common hydrate crystal forms listed in the Cambridge Structural Database (i.e.,
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neglecting non-aqueous solvates) are of the same crystalline space group with nearly
identical lattice constants. Among crystals of identical building blocks, the average
observable SHG intensity is dictated primarily by the crystalline space group. In the case
of these two hydrates (entry IDs RIGLAW and RIGKUP), the average observable SHG
intensities are assumed to be identical.
Raman images were acquired on an alpha300 AR commercial confocal
reflectance Raman microscope (WITec) with a 633 nm HeNe source, 35 mW output
(Melles Griot). A 10x objective (0.25 NA) was used, giving a beam waist of 0.8 m and a
depth of field of 20 m. WITec Control 1.60 was used for data collection. Specific fields
of view (300 m x 300 m) containing a region of interest within the bulk powdered
sample were first located via SHG, and then marked for subsequent confocal Raman
analysis. With the crystalline domain located at the center of the marked 300 m x 300
m field of view (FOV), re-positioning on the Raman microscope via bright field

imaging was quite reproducible, allowing the crystallite to be located via spectral analysis
with minimal searching. Each spectrum was acquired with four minute integration time,
followed by high-pass digital filtering to remove fluorescence background. Bench top
powder X-ray diffraction (PXRD) was acquired on a Rigaku SmartLab™ diffractometer
(0.1544 nm wavelength) scanned at one degree/min.

3.3 Results and Discussion
Figure 1 shows SHG images of four different batches (varying lot
numbers) of Abraxane®. Samples were imaged in powdered form, as received from the
manufacturer. All images are shown on the same brightness scale. Insets show line scans
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across a single particle in each batch in units of megacounts per second (Mcps). High
variation in crystallinity and particle number/ size between batches is readily observed.
A sample from batch 1 was imaged with SHG both before and after dissolution in
ultrapure water, the results of which are shown in Figure 2. This experiment was
performed primarily to exclude possible SHG interferences from the relatively small
fraction of buffer salts known to form noncentrosymmetric and therefore SHG-active
crystals.54 It would not be unreasonable for salts to exist within the formulation given the
use of HSA as the matrix. However, all such compounds are highly water soluble and
would not be expected to remain following addition of water to the sample. Furthermore,
solubilization in water mirrors the recommended procedure in preparation for parenteral
introduction. Figure 2 summarizes these results, showing a bright field image of
Abraxane® in the solid state (2a), bright field and cross-polarized images of individual
crystallites within Abraxane® suspension (2b) and SHG images of solid-state and
suspended Abraxane® (2c and 2d, respectively). SHG active areas remained even after
dissolution in ultrapure water combined with vigorous mixing, suggesting that the SHGactive material exhibited poor aqueous solubility and was unlikely to be an SHG-active
buffer salt. Additionally, these crystallites are likely to remain un-solubilized within
Abraxane® suspension.
Additional confocal Raman measurements were performed selectively on the
regions of interest identified as the SHG-active domains in the native Abraxane® dosage
form, the results of which are summarized in Figure 3. With initial screening by SHG, a
crystalline domain of interest (~20

m diameter) within a 300 m x 300 m FOV was

marked for subsequent analysis, shown in Figure 3a. Figure 3b summarizes the
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experimental Raman spectra acquired within the region of interest and elsewhere in the
FOV. For comparison, the experimental Raman spectra of pure PTX and pure HSA are
also shown. The Raman spectrum acquired from the SHG-active region of interest agrees
remarkably well with the measured spectrum of pure crystalline PTX. Furthermore, the
peak heights were notably greater in the SHG-active region, consistent with a higher local
concentration of PTX relative to other locations within the formulation. In addition, the
two peaks at 1007.1 cm-1 and 1604.3 cm-1 are most pronounced in the crystalline PTX
spectrum, as well as in that of the SHG-active region, but are only marginally detectable
in other locations within the formulation.
If the SHG-active and poorly soluble fraction of material in Abraxane® is
attributed to PTX, SHG microscopy can be used to estimate the relative crystallinity of
the active ingredient within the formulation. A calibration curve of SHG signal was
constructed from physical mixtures of crystalline PTX in HSA at various loadings,
accounting for the 10% (w/w) loading of PTX in Abraxane®. The PTX within batch 1
was found to be 30  13% (95% CI) crystalline, corresponding to 3.0% overall
crystallinity in the measured lot of Abraxane®. The relatively large uncertainty in the
crystallinity arose primarily from the limited volumes of materials probed, resulting in
statistical fluctuations in the crystalline fraction per probed volume. Such a large fraction
of PTX present in a crystalline state may potentially impact the effective dose of the
formulation. Analysis by PXRD failed to show any peaks, consistent with these relatively
low levels of crystallinity. A representative PXRD pattern is shown in the supporting
information, Figure SI-2.
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The spatial information afforded by SHG also allows assessment of the size
distribution of poorly soluble particulates in situ within the final dosage forms.
Histograms of SHG-active particle sizes are shown in Figure 4 for batches 1, 3, and 4 (4a
– 4c, respectively) as batch 2 did not contain enough particles to produce a meaningful
histogram. From these results, different lots exhibited diverse distributions, with particle
size ranging from <10 m to over 120 m. As the mass fraction probed by SHG
represents approximately 1% of the container contents, the observation of 37 particles
greater than 26 m within the imaged fraction of batch 1 suggests approximately 3700
(600) particles > 26 m present within the final dosage form, with the determined
standard deviation based on Poisson statistics. This degree of direct access to the size
distribution of insoluble crystalline particles would be challenging to obtain in situ within
the solid-state final dosage form using alternative standard methods given the optical
opacity of the Abraxane® formulation, but is reasonably straightforward to access by
SHG imaging. This initial screening by SHG greatly reduced the time required to perform
the Raman measurements. For a typical line-scan commercial Raman imaging approach,
the laser power required to obtain the SNR present in Figure 3 for a 256 pixel laser line
would be approximately 9 watts. In the assumption that this power does not represent a
laser-limited measurement, and decreasing the per pixel integration time to 30 seconds
(acceptable minimum SNR for identification), it would take approximately 8 hours of
continuous data acquisition to map out a given field of view with equivalent (512 x 512)
resolution, compared to 2 seconds/ FOV used for the SHG images. This represents a
reduction in the measurement time of over 2 orders of magnitude. It is further of note that
the SNR present in these SHG images (~500 for the line scan in Figure 1a) could be
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equivalently reduced, decreasing the required measurement time well into the video-rate
regime.

3.4 Conclusions
Using SHG microscopy to identify regions of interest within an amorphous
pharmaceutical formulation was found to enable targeted analysis by Raman
spectroscopy. By guiding Raman measurements to only these regions of interest, the
measurement time was reduced by over 2 orders of magnitude relative to established
bench top instruments. Characterization of the amorphous nanosuspension Abraxane®
illustrated this process for a drug formulation currently in clinical use. Substantial
variability in relative crystallinity was observed within the product as-received, with
water-insoluble particles up to 120 m observed in the formulation. SHG-guided
analysis by Raman spectroscopy was consistent with crystalline paclitaxel comprising the
poorly soluble particles. These combined results illustrate the potential benefits provided
by the marriage of the rapid and highly selective technique of SHG with information-rich
spectroscopic methods such as Raman.
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Figure 3.1 SHG images of batches 1-4 (A-D, respectively) of Abraxane®. Insets show
line scans across an individual crystalline domain for each image, in units of millions of
counts per second (Mcps). All images are shown on the same brightness scale. Large
variations in crystallinity are readily apparent.
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Figure 3.2 Bright field, cross-polarized, and SHG images of Abraxane® before and after
suspension in ultra-pure water followed by rigorous mixing. (A) Bright field image of
lyophilized Abraxane® powder. (B) i) and iii) Bright field images of individual
crystallites after suspension, ii) and iv) cross-polarized images. (C) SHG image of
lyophilized Abraxane® powder. (D) SHG image after suspension. Results show that
SHG active regions exhibit poor aqueous solubility. These results indicate that the SHG
active regions are unlikely to arise from water-soluble noncentrosymmetric buffer salts.
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Figure 3.3 SHG image of Abraxane and corresponding confocal Raman spectra after
digital high-pass filtering. (A) SHG image. (B) Raman spectra. The blue and red traces
shown in (B) were taken at the indicated locations of regions I and II, respectively. For
comparison, the black and green traces show the experimental spectra of pure PTX and
pure HSA (blank), respectively. Experimental spectra for pure PTX and for SHG active
domains in Abraxane® agree well. High SNR present at 1007.1 cm-1 and 1604.3 cm-1
within these two spectra are consistent with higher local PTX concentration within an
SHG active domain of Abraxane®.
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Figure 3.4 Histograms of crystal size for batches 1,3, and 4 of Abraxane® (A-C,
respectively) with occurrence reported as particle number density. Not enough crystallites
were present in batch 2 to produce a meaningful histogram. Insets show higher size
ranges. Crystals up to 120 m are present in Abraxane®, with substantial variability in
particle density and size between the measured batches.
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CHAPTER 4. PARTS PER MILLION POWDER X-RAY DIFFRACTION

4.1 Introduction
The chemical complexity of emerging drug molecules is rapidly increasing,
driven by the desire for more potent drugs with higher specificity and fewer side effects.
However, the growing chemical complexity presents challenges in developing
formulations that retain sufficient bioavailability. As a result of increased chemical
complexity, approximately 80% of potential active pharmaceutical ingredient (API)
candidates are in danger of being abandoned due to poor systemic exposure.1–3 APIs are
typically required to be sufficiently hydrophobic to pass through cell membranes and
enter the bloodstream to reach their targets. However, the hydrophobicity must be
balanced by a sufficiently high aqueous solubility. As the size and complexity of the API
increases, these mutually exclusive properties become increasingly difficult to
simultaneously satisfy.
Amorphous APIs are an attractive option for increasing the bioavailability of
poorly soluble APIs through the development of formulations containing higher free
energy solid state forms, with correspondingly faster dissolution rates.3–10 However,
amorphous APIs are typically metastable, with the potential to crystallize over timescales
that vary considerably from compound to compound, with external conditions such as
temperature and relative humidity, and with the matrix or formulation in which the API
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resides.11–14 Several strategies have been utilized to stabilize amorphous formulations,
including the use of polymeric crystallization inhibitors to form amorphous solid
dispersions (ASD), as opposed to amorphous API powders.6,7,15,16 Nevertheless, major
challenges emerge in assessing the long-term stability of amorphous formulations,
particularly for low API loadings and early stages of crystal formation. Underpinning all
of these formulation efforts is the need for sensitive, precise, and accurate analysis tools
for characterizing API crystallinity, particle size, and spatial distribution within
formulations, since each of these parameters can affect the release profile.
The most widespread current approaches used for assessing crystallinity in APIs
and API formulations include powder X-ray diffraction (PXRD),16,17 differential scanning
calorimetry (DSC),16 scanning electron microscopy (SEM),17–20 and spectrochemical
techniques such as Raman.17–26 However, each of these techniques faces significant
practical limitations in characterizing the spatial distribution of APIs, the characteristic
domain sizes, and even the presence or absence of crystallinity. The detection limits for
PXRD are typically on the order of a few percent crystallinity by mass. Similar detection
limits are generally observed for DSC, Raman, electron microscopy, and solid state
NMR. Currently the detection limits for percent crystallinity range from 0.2-5% for
existing methods. These limits can be problematic in studies of amorphous formulations
for which the total drug loading within an amorphous matrix may only be a few percent.
Recently, brighter X-ray sources from synchrotron facilities have been utilized as one
route for improving the detection limits of PXRD. Efforts using synchrotron X-ray
sources for powder diffraction have lowered the limits of detection for trace crystallinity
of APIs to approximately 0.2% crystallinity.27
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Second harmonic generation (SHG), or the frequency doubling of light, is particularly
well-suited for quantitative analysis of API formulations for several reasons. Firstly, the
symmetry requirements for even ordered nonlinear processes requires SHG to be highly
selective for noncentrosymmetric crystals, with negligible background contribution from
amorphous materials.28 The inherent chirality in most emerging APIs guarantees that the
resulting crystals will satisfy the symmetry requirements for SHG. Secondly, SHG shares
the same advantages as two-photon excited fluorescence by allowing imaging in turbid
media, as only the “ballistic” unscattered light surviving to the focal volume contributes
to the detected signal. Lastly, SHG exhibits a high intrinsic dynamic range of detection,
allowing quantification spanning ppm levels through 100% crystallinity. Previous studies
of model systems have suggested detection limits on the order of ppm for crystallinity
within amorphous solid dispersions.29–32
Despite the demonstrated capabilities of SHG for quantitative analysis in
amorphous pharmaceutical formulations, the nature of the signal provides little
qualitative information on unknowns. Many pharmaceutical formulations contain a
multitude of ingredients that can potentially produce SHG-active crystalline materials.
However, the SHG intensity alone is a relatively information-poor indicator for
composition within the crystalline components. Furthermore, reliable quantitative
analysis by the SHG intensity has previously required prior calibration on a materialspecific basis. As a result, methods that can provide qualitative determination of
crystalline composition at trace (ppm) levels would significantly improve the broader
utility of SHG for analysis of amorphous pharmaceutical formulations. Orthogonal
analyses at these low levels of crystallinity present their own analytical challenges. The
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following article describes a method capitalizing on the complementary capabilities of
SHG and XRD to yield crystallinity detection limits in the ppm range by XRD. By using
an SHG microscope to guide targeted XRD analysis, the detection of crystalline materials
can be achieved for samples that are deemed amorphous by conventional bench-top
PXRD analysis.

4.2 Materials and Methods
A combined instrument for SHG and XRD in a single, integrated platform has
been described in detail previously.33 Briefly, the SHG microscope was integrated into
GM/CA@APS beamline 23-ID-B at the Advanced Photon Source, Argonne National
Laboratory. The unattenuated photon flux for a 12 keV, 5 µm diameter beam using the
minibeam collimator34 was 1.5 x 109 photons/sec/µm2. The SHG microscope utilized a
FemtoPower 1060 laser (Fianium) with a repetition rate of 50 MHz, pulse width of <150
fs, and power at the sample of ~90 mW. The laser was focused to a spot size of 2 µm
with a 20 µm depth of field by a 10x objective with a numerical aperture of 0.35 (Optem,
28-21-10). The SHG signal was separated from the fundamental by a series of dichroic
mirrors (Semrock FF555-Di03-25x36, Chroma z1064rdc-sp) and filters (Chroma
HQ530/30m, and CVI, 03FCG567/KG3), and detected using photon counting modules
(Hamamatsu, H10722-10). Beam scanning was achieved by use of an 8 kHz resonant
scanning mirror (Cambridge Technology, 1-003-3002509) moving along the vertical (y)
axis and a galvanometer stepping mirror (Cambridge Technology, 6210H) moving along
the horizontal (x) axis to generate images with a 300 x 300 µm field of view and a 2 µm
pixel size. All SHG images were integrated for 1000 sweeps per line (~20 sec/image). All
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software for the scan mirror control and data acquisition was written in-house. The
general workflow for the SHG-guided XRD analysis is shown in Figure 1.
The diffraction patterns were analyzed and indexed by the software packages
Fable and GrainSpotter.35 The positions of the diffracted peaks are retrieved frame by
frame based on a single intensity threshold and combined into a g-vector file. The gvector file stores the peak positions in 3D coordinates, where individual frames are sitting
in the x-y planes with the tilt angles in the third dimension. GrainSpotter then generated
numbers of theoretical diffraction patterns based on the reported Ritonavir (RTV) crystal
structure among the different crystal orientations and built a lookup table for indexing. A
built-in algorithm automatically matched the peaks in the g-vector space with the lookup
table and reported the crystal orientation when it found an overlay in good agreement
with the observed experimental diffraction pattern. Once the crystal orientation was
obtained, the theoretical diffraction patterns at this particular orientation were generated
by the PolyXSim and compared with the experimental data.1D powder-type patterns are
recovered via azimuthal autocorrelation (i.e., along a constant radius, or 2θ value) of the
2D image. As only discrete spots are present in these images, integrating or averaging
along this dimension artificially diminishes the observed SNR for these reflections.
Rather, autocorrelation preserves the 2θ locations and intensities of individual reflections
while removing the amorphous scatter arising from the glass substrates surrounding the
sample.
The physical mixture of 100 ppm ritonavir (Astrix Labs, India) in hydroxypropyl
methylcellulose (Shin Etsu, Japan) was prepared via serial dilutions with geometric
mixing. Portions of each sample were then sandwiched between two number 1 coverslips
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to achieve a uniform sample thickness of ~150 µm, with two coverslips serving as
spacers on either end. The coverslips were then mounted on the goniometer for combined
SHG and XRD analysis. Ritonavir was chosen as a representative model system, in part
because it exhibits mid-range SHG activity compared to a suite of small molecule APIs36
and the polymorphic purity of the commercial product is well established.37 The ritonavir
was used as received from the manufacturer.
SHG imaging for assessment of overall crystallinity was performed on a system
described in detail previously.38 Each of 110 fields of view were comprised of multiple
images corresponding to adjacent planes in the z direction (i.e., parallel to beam
propagation), with each plane integrated for approximately 2 seconds at a laser power of
50 mW. Post-acquisition, the in-focus plane from each field of view was isolated for
analysis. NIH ImageJ was used to threshold each representative plane and assess particle
number and size.39

4.3 Results and Discussion
Particle sizing and counting was performed on a large (>100) set of SHG images
to independently quantify the level of crystallinity within a physical mixture (PM) of
RTV in hydroxypropyl methylcellulose (HPMC). Figure 2a and 2b show two
representative SHG images of 100 ppm (w/w) RTV in HPMC. Figure 2c shows a
histogram of particle volumes for the pooled data set.
Comparisons of the SHG active volumes to the total probed sample volumes can
be used to provide estimates of the overall crystallinity present with the physical mixture.
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An overall crystallinity of 230 ppm (v/v) was recovered for the imaged fraction of the
100 ppm (w/w) PM.
While the recovered crystallinity by SHG differs from the expectations based on
gravimetric analysis by approximately a factor of two, several potential sources of error
could account for this difference. First, the PM was prepared as 100 ppm by weight.
However, using the SHG images to estimate the crystallinity produces an estimate by
volume. Second, the relative densities and packing densities of both RTV and HPMC
could affect the calculated crystalline content. While the combined effect of these
variables is difficult to estimate, observed variations in the packing density of HPMC and
other pharmaceutical excipients suggest that variations in these quantities, in addition to
the absolute density difference between HPMC and RTV, could introduce sufficient error
to account for this difference.40,41 Third, although the number density of crystallites
observed between the >100 raw images suggests a sufficiently wide sampling of the
powder aliquot via SHG, it is possible this ~mg aliquot is not representative of the ~kg
bulk PM. Finally, the total volume of material probed by SHG was approximately 0.5 L.
At a loading (by volume) of 230 ppm, this corresponds to ~100 pL of total crystalline
material probed. Considering these combined factors and the exceedingly small volume
of crystalline sample probed, the recovery of a percent crystallinity within 130 ppm of the
anticipated value based on gravimetric analysis is encouraging for future quantitative
studies.
Prior to combining SHG with synchrotron XRD, diffraction data were acquired
for a single crystal of RTV across 120 different crystal orientations within the
diffractometer. Figure 3 illustrates the effect of preferred crystallographic orientations in
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XRD. Total time required to acquire the full tilt series was 2 minutes per location, with
another ~2 minutes of total dead time for sample repositioning between exposures. While
only a fraction of all possible reflections are observed for the single frames (1 degree
integrations) in Figure 3a and Figure 3b, summation of the diffraction patterns through
the 120 crystal orientations begins to recover the anticipated PXRD pattern retrieved
from the Cambridge Structural Database (CSD) (Figure 3c red trace). It is noted that the
relative peak heights differ from the theoretical pattern from the CSD. This observation is
expected, as only a subset (varying only one rotation axis through 120) of all possible
orientations is contributing to the summed pattern in Figure 3c (blue trace).
From both the raw diffraction data and the pooled results shown in Figure 3,
preferred orientation effects from a single orientation of the sample can complicate
analysis by synchrotron XRD, as only a subset of all possible Bragg reflections will
appear simultaneously if only one or a few orientations from a finite number of
crystallites are probed in the course of a measurement. Such effects can complicate both
qualitative chemical identification of a crystal and quantitative determination of volume
fraction, as both peak location and relative amplitude for a given reflection can vary
significantly based on the orientation of the crystal. For trace crystal detection, in which
only a relatively few total number of crystals may be used in the complete analysis, these
crystal orientation effects are particularly pronounced.
In single crystal diffraction analysis, indexing provides a route for effectively
allowing crystal orientation to be used as an advantage rather than a limitation in
diffraction analysis. Figure 4b shows the indexing of a zoom-in of the diffraction image
shown in Figure 4a using the Fable software package.35 Experimental reflections are
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shown in black, while theoretical reflections for the determined crystal orientation are
shown in red. The indexing process successfully recovers the known crystal orientation
across each of the 120 diffraction images, assuming explicitly the lattice constants
obtained from the CSD (entry ID YIGPIO03). Such an approach suggests the validity of
indexing to subsequently confirm the identity of a crystal by XRD, after pre-identified for
analysis by SHG.
The combination of SHG microscopy with synchrotron XRD has the potential to
significantly lower the limits of detection for trace crystallinity within an amorphous
medium, as demonstrated in Figure 5. Analysis of the same 100 ppm (w/w) mixture of
RTV in HPMC, shown in Figure 5, by conventional benchtop PXRD results in no
significant experimental evidence for the presence of crystallinity (Figure 5c). However,
through SHG guided synchrotron XRD, the trace crystallinity is readily detected as seen
in Figure 5b. The diffraction pattern for the region with the greatest signal in the SHG
image (Figure 5a) is shown in Figure 5b. The anticipated reflection positions based on the
indexing results and recovered single crystal orientation are also included in Figure 5b
(solid red spots). The red circles in Figure 5b indicate the areas where the indexing and
experimental diffraction match. The observed reflections are consistent with the assumed
lattice parameters for RTV, supporting the ability to characterize crystallinity within a
trace (100 ppm) crystalline sample by SHG-guided synchrotron XRD. Diffraction images
of multiple SHG-inactive regions, taken with the identical beam size and exposure time,
do not show any observable reflections, further suggesting that the observed diffraction is
unlikely to be arising from the excipient polymer matrix.
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SHG-guided diffraction analysis also offers two key quantitative advantages
regarding the observed signal-to-noise ratio (SNR) in the measurements. The first
advantage is through background reduction. The rapid identification of crystal location by
SHG allows X-ray diffraction analysis with a small (10 m) beam. Significant
background from amorphous scatter is arguably one of the most common factors
contributing to the relatively high detection limits of traditional PXRD measurements.
The volume of amorphous material probed is reduced by using the minibeam collimator
to pair the size of the X-ray source to that of the crystalline sample, resulting in a
lowering of the background scatter from amorphous contributions.34 The second SNR
advantage arises from the reduction in spectral congestion. The diffraction features in the
single-crystal measurements are well separated in angle from other diffraction features,
while multiple peaks can be highly overlapping in conventional powder XRD.

The

observed SNR in the diffraction measurements in Figure 5b is ~5000 from a 1 second
exposure with a 5 µm diameter beam. Given the sixth power dependence of diffraction on
crystal diameter, this SNR corresponds to a minimum detection limit for a single crystal
on the order of 2 µm, assuming a 5 µm diameter beam.
In addition to the SNR advantage in the X-ray analysis, the integration of SHG
imaging also offers a significant time savings in the identification of crystalline domains.
Although in principle, background suppression could be broadly achieved by localization
of the X-ray source, the relatively long integration time per pixel (1 s in the present
study) represents a considerable cost. Some time savings can be expected through
iterations first using a spatially broad source to identify regions of interest based on
observed diffraction, then progressing to smaller diameter beams for SNR optimization.
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However, this strategy will be limited to relatively large crystals to overcome the
background with a wide-area source and can still require several hours of synchrotron
beam time. By first targeting the diffraction to regions of interest (ROIs) within ~1 µm
resolution rapidly identified by SHG, high SNR diffraction can be collected in a matter of
seconds.
Although all the measurements reported in this study were performed with an
integrated instrument combining SHG with synchrotron XRD in a single platform, this
general strategy for SHG-guided diffraction is not limited to this one architecture. If the
SHG-active ROI can be reliably and accurately located through the use of any set of
inherent or artificial fiducial markers, combined measurements could in principle be
obtained through pre-screening on a benchtop nonlinear optical microscope followed by
diffraction on an independent beam line. For small crystals, the integrated system has the
advantage of absolute accuracy in the positioning between SHG and synchrotron XRD to
within 1 µm. However, for larger crystals off-line analysis may still provide the accuracy
required for structural characterization.
Off-line measurements would also have the advantage of allowing for integration
with complementary methods for structural analysis, such as Raman spectroscopy. SHGguided Raman spectroscopy has recently been used to study a commercial formulation of
nanoparticle albumin-bound paclitaxel.42 Increasing the number of orthogonal
measurements of the same sample significantly improves the overall confidence of the
conclusions drawn, with Raman potentially serving as a relatively simple first-pass
analysis approach prior to synchrotron XRD. XRD is arguably the gold standard for
crystal characterization, in many cases showing a more sensitive response to subtle
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variations in crystal structure and form than common orthogonal techniques such as
Raman, DSC, and SEM. The high (>5000) SNR observed in the diffraction images of 100
ppm RTV in HPMC illustrate these advantages. Additionally, the detector integration
time required for thorough characterization of crystal form by synchrotron XRD (<< 1
second) is significantly lower than that required for the Raman measurements performed
in the previous study (on the order of several minutes). As construction of new
synchrotron facilities continues worldwide, the overall availability and utility of SHGguided XRD has the potential to increase concurrently.
The generalizability of this technique can be assessed from previous
measurements done using bench-top instrumentation. The integrated diffraction for any
small molecule organic API crystal is likely to be similar, with much greater anticipated
variability in the SHG activity. Fortuitously, previous experiments have shown a 7 orders
of magnitude detectable dynamic range for the observed SHG intensity of 42 different
APIs under comparable imaging conditions.36 The SHG activity of RTV falls in the midrange of this scale, suggesting viable detection for the majority of homochiral crystalline
APIs. From previous studies of common excipients, it is reasonable to suggest that the
approach described herein will have few constraints arising from the selection of polymer
matrices in amorphous solid dispersions. From these combined results, it is reasonable to
suggest that SHG-guided micro-diffraction is likely to be a broadly applicable approach
for both detection and analysis of trace homochiral crystallinity within amorphous solid
dispersions.
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4.4 Conclusions
SHG microscopy and synchrotron XRD were coupled to detect trace crystallinity
of an API in a common formulation excipient. The combined instrument was able to
detect 100 ppm (w/w) ritonavir in HPMC, decreasing the limit of detection by more than
1 order of magnitude over previously reported values.27 Using SHG to guide synchrotron
XRD analysis provides two main advantages over PXRD. First, SHG allows for rapid
detection and localization of areas containing crystalline APIs. The SHG images can be
acquired in a matter of seconds, whereas the same field of view would be prohibitively
time-consuming to image via XRD raster scanning. Secondly, SHG-guided diffraction
allows background suppression in the XRD through the use of a 5 µm diameter source
better matched to the dimensions of the crystalline domains. Such low detection limits
have the potential to enable substantially faster turn-around times in optimization of
amorphous solid dispersions, in which even trace crystallinity can substantially impact
the bioavailability in final dosage forms.
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Figure 4.1 Experimental work-flow for SHG-guided synchrotron XRD analysis of trace
crystallites. First the amorphous solid dispersion is imaged using an IR source. The
resulting SHG image is then used to guide the synchrotron to the regions of interest for
diffraction analysis.
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Figure 4.2 SHG images and generated histogram of particle volumes for 100 ppm
ritonavir in HPMC. (A) and (B) SHG images. (C) Recovered histogram. The SHG-active
fraction of material can be used to assess overall crystallinity of the powdered blend.
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Figure 4.3 Single crystal diffraction patterns for Ritonavir. Diffraction patters were
obtained for 120 different angles with representative diffraction patterns from two
different angles shown in A and B. A simulated powder diffraction is obtained by
summing all of the single diffraction images together (blue trace in C) and compared to
the predicted powder pattern obtained from the CSD (red trace in C). Even though the
experimental pattern was obtained from only a small subset of crystal orientations it is
beginning to approach that of the predicted pattern.
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A

B

Figure 4.4 Results of diffraction indexing for Ritonavir. A) Single crystal diffraction
pattern for ritonavir. B) Single crystal diffraction pattern generated by the Fable software
suite based only on lattice parameters from the CSD entry for Ritonavir (red dots,
overlaid). Excellent agreement is observed between experimental and theoretical
diffraction patterns indicating that the indexing method can correctly recover single
crystal diffraction patterns without knowing the orientation a priori.
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Figure 4.5 Analysis of a 100 ppm sample of ritonavir in HPMC (0.01% w/w) with
SHG-assisted synchrotron XRD. Where a) is epi-SHG signal from ritonavir, with the red
crosshairs denoting the center of the synchrotron X-ray beam. An XRD pattern of the
SHG active region (circled in yellow) is shown in b along with the results from the auto
indexing (red dots). Areas where the auto indexing results and experimental diffraction
pattern agree are highlighted by the red circles. The powder XRD spectrum using a
conventional PXRD benchtop is shown in c and indicates that the sample is amorphous
by conventional PXRD.
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CHAPTER 5. POLARIZATION-MODULATED SECOND HARMONIC
GENERATION ELLIPSOMETRIC MICROSCOPY AT VIDEO RATE

5.1 Introduction
The information content of NLO microscopies such as SHG can be enhanced
through the recovery of Jones tensor elements via polarization-dependent measurements.
The Jones tensor for SHG describes the relative efficiency of frequency doubling given
defined polarizations (horizontal or vertical, “H” or “V” respectively) for the two incident
photons (frequency ) as well as the exiting photon (frequency 2).1 For SHG, in which
the two incident photons are indistinguishable, this yields 6 total Jones tensor elements
for a given sample. As these Jones tensor elements should vary with changes in structure
and orientation of the sample, recovery of these parameters yields new information
potentially inaccessible by traditional measurements relying only on recovery of the
integrated intensity. Polarization-dependent SHG measurements have seen a rich history
in a variety of analyses, including characterization of collagen2–4 and cell membranes,5 as
well as analysis of tissues in disease diagnosis and monitoring.6–10 Polarization-dependent
SHG measurements have also been used for characterizing inorganic materials,11–13
protein crystals,14 and surfaces/ monolayers.15,16
Unfortunately, the majority of previous instruments for polarization modulation in
NLO microscopies have relied on the manual rotation of optical elements (e.g., waveplates, polarizers) for modulation of the incident field and polarized detection of the
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exiting field.15,17 Such architectures generally yield long data acquisition times, as
acquisition of complete data sets requires repeated imaging at a large number of optical
element rotations. Such approaches are not compatible with in vivo imaging or highthroughput measurements, in which complete image acquisition must be accomplished at
or near video rates for practical implementation. A number of previous strategies have
sought to increase imaging frame-rates in polarization-dependent NLO microscopies.
Stoller et al3 used polarization modulation at 4 kHz together with sample scanning to
image collagen assemblies in rat tail tendon. Tanaka et al18 used an electro-optic
modulator to cycle between two fixed incident polarizations. Lien et al19 demonstrated
the use of a liquid crystal modulator (~kHz frequencies) in SHG imaging. Unfortunately,
most of these past approaches still require at least several seconds of integration time per
frame, with acquisition times up to several hours per frame. Additionally, none of these
previous efforts recover Jones tensor elements for the sample, but rather often utilize
multivariate or fourier transform (FT) based analyses. The ability to recover sample
tensor elements at video rates in NLO microscopies could be a powerful new technique
for tissues analysis, high-throughput structural characterizations, and fundamental studies
of NLO theory and materials.
Rapid (8 MHz) polarization modulation via an EOM, combined with synchronous
digitization (SD) has enabled recovery of Jones tensor elements in SHG microscopy at up
to 15 Hz frame rates. Recovery of these Jones tensor elements is termed nonlinear optical
Stokes ellipsometry (NOSE). Following characterization of the EOM response for
recovery of the incident polarization states, validation of the system was demonstrated
through recovery of the Jones tensor elements for Z-cut quartz at a well-defined
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orientation. Polarization-dependent imaging at video rates is then demonstrated with a
sample of naproxen microcrystals. Finally, polarization-dependent SHG images are used
to identify twinning in a crystal of the protein glucose isomerase. These combined results
demonstrate the utility of video rate NOSE in a variety of application spaces.

5.2 Theoretical Foundation
The relationship between the detected intensity and a modulated incident
polarization state in NOSE has been described in detail in previous works15,17,20 and is
briefly summarized herein. In linear optics, polarization states and optics can be
described in terms of well-established Jones vectors and Jones matrices, respectively.
Examples of this mathematical framework are given in Tables 5.1 and 5.2. Recently, this
framework has been extended to introduce the concept of Jones tensors as polarization
transfer tensors.21,22 By analogy with Jones matrices, knowledge of the Jones tensor
allows one to predict all polarization-dependent observables of a given measurement as a
function of the incident polarization state or states. In this framework, the Jones matrix
for the EOM rotated an angle  is given by the following expression.
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The time-dependent phase shift of the EOM, (t), is in turn sinusoidally
modulated.
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In Eq. 2, A represents the amplitude of modulation, f0 is the modulation frequency in
cycles/s,  is the phase shift between the driving sinusoidal function and the experimental
phase of the EOM, and B is the constant residual phase shift inherent in the EOM.
We have previously derived expressions relating the Jones tensor elements to the
intensity of n-polarized SHG where n is either v or h for vertical or horizontal
polarization, respectively.15,17,20
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In the above equation, the -terms indicate individual elements from the 2×2×2 (2) Jones
tensor. From this above equation, it is clear that the measured intensity can generally
recover up to 5 unique parameters ultimately dependent on three nonzero tensor
elements, which in general are complex-valued. Since the number of real and imaginary
unknowns exceeds the number of observables by one, only the relative phase between the
tensor elements can be recovered, which is similar to conventional ellipsometry
performed for surface analysis. Far from resonance and in the absence of birefringence in
the sample, B and D are zero-valued, reducing the number of observable down to three,
paired to the number of unique elements within the Jones tensor for a given polarization
state of detection.
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In practice, it is often more convenient to perform the linear fitting to an
alternative set of Fourier functions. Conversion from the polynomial to Fourier
coefficients is performed through simple matrix multiplication. The use of Fourier
coefficients also provides direct comparison with alternative measurements performed by
lock-in detection.3 In this framework, the detected intensity is described by the following
analytical expression.
2
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Interconversion between the two sets of coefficients can be achieved by simple matrix
multiplication.
 A  1 1 1
 B  0 0 0
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An analogous framework can be used to describe the polarization-dependent
transmittance of the incident infrared beam, which in turn provides information on the
sample birefringence. In brief, the intensity of the transmitted beam under the conditions
identical to those used for the SHG measurements is given by the following expression.

I det
    a  b cos     c sin   

5.7

From Eqs. 5 and 7, it should be clear that the detected response will generally
exhibit amplitude and phase terms for both the fundamental and second harmonic in , in
addition to a constant term. However,  is itself sinusoidally modulated in time. As a
result, direct recovery of the Fourier coefficients from the -dependent intensity is
straightforward, but analogous quantitative analysis based on the harmonics of f0 from the
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time-dependent intensity with sinusoidal modulation is not trivial. Previous early efforts
have addressed this challenge by using sawtooth modulation that is linear in time.3
However, this strategy is challenging to implement at high speeds because of the much
larger bandwidth required to drive sawtooth modulation at MHz frequencies relative to
sinusoidal modulation. In the present case, the use of a resonant tank circuit significantly
increased the amplitude of modulation (which can be challenging at radio frequencies)
and improved the stability through bandwidth reduction, but was fundamentally
incompatible with sawtooth modulation.
The preceding treatments are valid within the paraxial approximation consistent
with low numerical aperture lenses and objectives as used in the present study. However,
it is relatively straightforward in principle to extend this mathematical framework for
polarization analysis to high numerical aperture objectives in which the electric field has
projections along all three spatial coordinates, as detailed explicitly in previous work.21 In
brief, the matrix-notation for propagation of the electric fields as presented in the present
study allows the influence of tight focusing to be incorporated through multiplication by
an additional “local field” matrix. This additional matrix relates the incoming and exiting
local fields experienced within the focal volume to the far-field polarization state detected
in the laboratory frame. Consequently, the present polarization modulation approaches
can be easily extended to analogous measurements performed with high numerical
aperture objectives.
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5.3 Materials and Methods

5.3.1 Instrumentation
SHG and laser transmittance imaging was performed on a custom microscope
adapted from an instrument described previously13,23,24 and shown schematically in
Figure 1. Briefly, an 80 MHz 100 fs MaiTai Ti:sapphire laser (SpectraPhysics) tuned to
800 nm was used as the incident light source for both SHG and laser transmittance
imaging, with average powers between 20-220 mW. The beam was scanned across the
sample using a resonant scanning mirror at 8 kHz (EOPC) synchronized to the laser and a
galvanometer mirror (CambridgeTech) in the fast and slow axes, respectively. The beam
was passed through an EOM rotated 45o from its fast-axis. A Soleil-Babinet compensator
was placed after the EOM to correct for polarization changes induced by the rest of the
beam path and microscope components. The beam was then directed through a telecentric
lens pair and square aperture to block the turning points of the sinusoidal resonant mirror
trajectory. The scanned beam was focused onto the sample with a 10X , 0.3 NA objective
(Nikon). SHG and fundamental light were separated using a dichroic mirror and collected
in the transmitted direction. The SHG signal was separated into its horizontal and vertical
components with a Glan-Taylor polarizer, which were detected on two photomultiplier
tubes (PMTs) (Hamamatsu H12310-40) with bandpass filters (HQ 400/20m-2p; Chroma
Technology) to further reject the fundamental. The transmitted fundamental light was
detected with a photodiode (Thorlabs DET-10A) after passing through a Glan-Talyor
polarizer set to pass horizontal, allowing for simultaneous polarized laser transmittance
imaging and SHG imaging.
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5.3.2 Data Acquisition
Data acquisition was performed using SD.24 A schematic of the synchronous
timing control required for SD is depicted in Figure 1. Two PCIe digitizer cards
(AlazarTech ATS-9350) were used to flash digitize the SHG and laser transmittance on
three channels synchronously with the laser. Custom software was designed to record
digitized voltages as 32-bit numbers. The 80 MHz signal from the laser’s internal
photodiode was used as the master clock. The laser clock was sent through a custom
timing module, where it was amplified, shifted, and divided by 8, to produce a 10 MHz
square wave. The synchronous 10 MHz signal was sent to the onboard 10 MHz phaselocked-loop of the digitizer card, and the digitizer card was set to digitize at 80 MHz
synchronously with the laser.
Due to the high Q-factor of the resonant mirrors (Q > 250) amplitude stability was
achieved at the sacrifice of phase stability. To correct for this drift in phase stability, a
custom control box was designed and built to perform real-time active phase correction
of the resonant mirror. The resonant mirror timing box was controlled by an 8-bit
microcontroller (Silicon Laboratories, C8051f120), running at 80 MHz derived from an
external 10 MHz phase-lock loop (PLL) synchronous with the 80 MHz master clock from
the Ti:Sapphire laser, allowing for precise knowledge of the number of laser pulses per
resonant mirror trajectory. The microcontroller ran a custom built operating system using
a combination of hardware and software timers to produce the mirror drive signal. The
feedback of the resonant mirror was analyzed by the box, and corrections to the driving
phase were made to maintain phase stability of the resonant mirror. Phase corrections
were performed to a precision of 25 ns, or two clock ticks from the master clock. A
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monitor output signal from the mirror driver box was sent to the trigger input on the
digitizer card. A synchronous ramp signal generated by the timing module was used to
control the galvanometer mirror by incrementing the angle of the mirror after every pass
of the resonant mirror.
The signal transients from each individual detector response from every laser
pulse were digitized synchronously with the laser. A 3-13 ns electronic digital delay stage
was added between the master clock (10 MHz) signal and the PCIe digitizer cards to
allow for adjustment of the phase of digitization relative to the signal generation to
account for the absolute time difference of the clock and the optical path. The resultant
data were then binned following a sine-wave trajectory, resulting in higher density of
sampling near the turning points of the trajectory, with the corresponding data analysis
accounting for this sampling density.

5.3.3 Polarization Modulation
Synchronous polarization modulation was performed using a custom-built
extended length EOM (Conoptics). A third 10 MHz output from the timing module was
used as an external clock source for a function generator, which was used to generate an
8 MHz sine wave. The 8 MHz signal was amplified using a high voltage amplifier (AR
Worldwide KAW1040) combined with a custom built resonant tank circuit and used to
drive the EOM beyond its half-wave voltage. The period of the resonant mirror was
carefully chosen using its driver box, so that the number of laser pulses per image was an
integer multiplier of the number of polarizations used to ensure that each frame began
with the same starting polarization. For the described experiments, the laser frequency

74
was 80 MHz and the EOM was driven at 8 MHz for a total of 10 unique elliptical
polarizations. Custom software (Matlab) was developed to separate out each laser pulse
to generate the 10 polarization-dependent images in real-time. To ensure all 10
polarizations were sampled in one trajectory of the resonant mirror, pixels were binned in
the fast-axis to generate images that were 300 by 512 pixels. After acquisition, images
were resized to 512 by 512 pixels using image interpolation (ImageJ).

5.3.4 Sample Preparation and Imaging
Polarization-dependent imaging was performed on z-cut quartz (500 µm
thickness) at various rotation angles about the z-axis. Images of z-cut quartz were
acquired with 20 mW average power with 32 frames averaged together. Polarizationdependent imaging was performed on naproxen recrystallized in isopropanol with 95 mW
average power. Video rate imaging was performed to generate polarization-dependent
movies of the sample being translated using an automated sample stage (Prior). Still
images of naproxen crystals indexed matched in Type A immersion oil were acquired
with 64 frames averaged. Glucose isomerase was obtained as a crystalline suspension,
and was dialyzed against 10 mM HEPES, 1 mM MgCl2 and 100 mM HEPES, 10 mM
MgCl2. The protein solution was concentrated to 26 mg/mL in water and crystallized in 0.
7 M sodium citrate tribasic dihydrate at pH 7 in 96 well sitting drop crystallization trays
(Corning). Polarization-dependent imaging of glucose isomerase crystals was performed
in situ with 225 mW average power and averaged for 2000 frames. Images were acquired
in 3D through the drop using automated focus control (Prior) with steps 15 µm in the zdirection.
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5.4 Results and Discussion
Before the Jones tensor elements for a given sample can be extracted from the
polarization-dependent SHG images, the polarization state of each laser pulse incident on
the sample must be characterized. Knowledge of the specific polarization state of the
incident field requires characterization of the modulation imparted by the EOM according
to equation 5.2, in which the amplitude, frequency, and phase of modulation, in addition
to the overall phase relationship between the EOM and the laser repetition rate, all dictate
the specific polarization state for each laser pulse. Polarized detection of the transmitted
incident field (in the absence of any sample) allows recovery of the values of  according
to equations 5.1-5.2 through a least-squares nonlinear fit. Figure 5.2 shows two nonlinear
fits used to characterize the EOM based on the transmitted laser fundamental (5.2a) and
SHG from Z-cut quartz, a single-crystal material with well-defined Jones tensor
elements, at a known orientation (5.2b). The recovered sinusoidal modulation (in time) of
the EOM recovered from each method in 5.2a and 5.2b is shown in 5.2c, with results
between the two fits showing reasonable agreement. 5.2d illustrates the probed values of
delta given the repetition rate of the ultra-fast laser used in the experiments (equally
spaced points on the y-axis).
Although a relatively subtle offset remains between the two calculated phase
angles (Figure 5.2c), the good overall agreement suggests that the incident polarization
state can be reliably recovered from measurements of the polarized infrared beam.
Uncertainties in the parameters A, δ and B from eq. 5.2 were determined through
numerically calculating the second derivative around the minimum of chi-square space as
described elsewhere and propagated to determine the standard deviation in the phase

76
values obtained from the fit.25 The values derived from the nonlinear fit for A, δ and B
were 1.90 ± 0.04, 1.18 ± 0.02 and 1.10 ± 0.02, respectively, and the standard
deviations for  are all ~± 0.04, indicated by the error bars shown in Figure 5.2d.
Following characterization of the polarization state imparted by the EOM,
polarization-dependent SHG images of Z-cut quartz were used to confirm successful
recovery of Jones tensor elements by NOSE microscopy (equations 5.3 – 5.6). After
linear fitting of the polarization-dependent SHG intensity (function of ) to recover
Fourier coefficients a-e, equation 5.6 was used to convert the Fourier coefficients to a set
of polynomial coefficients, which can in turn be used to directly solve for the sample
Jones tensor elements (equation 5.4). Recovery of Jones tensor elements was completed
for seven different orientations of Z-cut quartz to establish experimental uncertainties.
Table 5.3 compares the recovered Jones tensor elements for Z-cut quartz ( one standard
deviation) with theoretical values.1 Agreement between the experimental and theoretical
values is observed. The experimental and theoretical values of the Fourier coefficients
across a variety of Z-cut quartz rotations were also compared. Figure 5.3 shows both
experimental and theoretical values for both the horizontally and vertically polarized
detectors for coefficients a and b across 40 different rotation angles of Z-cut quartz.
General agreement is observed. Departure between the theoretical and experimental
coefficient values is attributed primarily to uncertainty in the polarization state (),
imperfections/ birefringence in the Z-cut quartz, and the breakdown of the paraxial
approximation yielding non-zero projections of the polarization state in the direction of
beam propagation.
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Following validation of the method by Z-cut quartz, NOSE images of Naproxen
microcrystals were acquired to demonstrate 1) the utility of the method for the analysis of
active pharmaceutical ingredients (APIs) and 2) the use of the Fourier coefficients as a
complete, concise, and sample-independent method of storing and communicating the
polarization-dependent SHG response. The specific Jones tensor elements that are nonzero vary based on the sample lattice symmetry (higher symmetry yields more zerovalued tensor elements) and orientation, and thus require processing steps that are
sample-dependent. In contrast, the process of linear fitting to recover Fourier coefficients
a – e is the same for every sample in the present approach. As the entirety of the
polarization-dependent information content is contained within these coefficients, they
provide a complete representation of the measurement. Furthermore, they can be encoded
into a single image based on a red, green, blue, cyan, magenta (RGBCM) color scale,
allowing reduction of the dimensionality of a single channel’s response from ten (number
of unique values of  probed in the course of a NOSE measurement) to one. The process
of polarization-dependent imaging, linear fitting for coefficients a – e, and RGBCM
mapping is shown in Figure 5.4. 5.4a represents a traditional SHG image based off the
total integrated intensity. 8 MHz modulation on the EOM yields 10 unique polarization
states (5.4b) given the 80 MHz repetition rate of the ultrafast laser used here-in.
Following linear fitting, the five Fourier coefficients can be assigned a unique color
(5.4c), where the intensity of each color is directly related to magnitude of the coefficient
value. Merging these five images into one red, green, blue, cyan, magenta (RGBCM)
image is shown in 5.4d. Communication of the scales used for color mapping together
with the RGBCM image allows complete recovery of all polarization-dependent
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information probed in the course of the measurement, serving as a convenient starting
point for exploration of a variety of subsequent data analysis methodologies.
Finally, crystals of the protein glucose isomerase were imaged to assess the
capability of NOSE microscopy for characterizing protein crystal quality. In the field of
structural biology, multi-domained crystals can complicate solving a crystal structure by
XRD.26 A means of rapidly assessing overall crystal quality prior to XRD could help
keep low quality targets from entering time-consuming XRD pipelines. Figure 5.5 shows
a laser transmittance image (5.5a) of a glucose isomerase crystal. 5.5b uses principal
component analysis (PCA) of the polarization-dependent images to visualize differences
in the polarization-dependent response from different domains of the crystal.14 While
grayscale differences are observed, these differences are arguably accentuated in the
merged RGBCM color map shown in 5.5c, indicating clearly the presence of twinning in
this particular glucose isomerase crystal. In addition to providing improved contrast
between crystalline domains, NOSE microscopy has the distinct advantage of not
requiring any training of the algorithm as does PCA.
It is interesting to compare the NOSE microscope figures of merit to those of
previous single-point nonlinear optical ellipsometry instruments.17,20,22,27–29 At video rate,
pixels in the central field of view are sampled with as few as 12 consecutive laser pulses,
each of which corresponds to one of the 10 possible polarization states produced by the
EOM. The value of 12 laser pulses represents a minimum, with a greater number of
pulses sampled per pixel near the edges of the fast scan axis where the resonant mirror
was moving the beam more slowly. Compared to the 12.5 ms acquisition time used
previously, the minimum per-pixel acquisition time for z-cut was 4.8 s (32 averaged
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frames, each 150 ns), representing a 2600-fold reduction in the measurement time.
Assuming noise is dominated by Poisson fluctuations in the detected intensity, this
change corresponds to an anticipated reduction of ~50 in the signal to noise ratio (SNR)
relative to the previous polarization measurements by NOSE. In that prior work, quartz
tensor elements could be determined in 12.5 ms with a SNR of ~100. Reducing this value
by a factor of 50 yields a SNR ratio of approximately 2 in 4.8 s. In practice, the
measured SNR in a single pixel in an integration time of 4.8 s in the current NOSE
experiments was typically approximately 5-6, representing approximately a 3-fold
increase over previous experiments. The most likely explanation for the improvement in
the SNR in the present work is the higher signal level achievable using fast scanning and
synchronous digitization for high dynamic range detection rather than photon counting as
was done in the previous work.
Due to the presence of distinct frequencies in the polarization-dependent crystal
response (e.g., eq. 5.5), it may initially appear that lock-in amplification (LIA) could be
an attractive alternative to the data acquisition strategy presented here-in. However, the
harmonics present in equation 5.5 are a function of the polarization state (), not time. As
equation 5.5 contains further trigonometric functions of a sinusoidal modulation (the
EOM response, eq. 5.2), direct time-domain LIA of the polarization-dependent response
would only be valid at very lowly modulation amplitudes such that the harmonics in 
correspond with harmonics in time. Such a change would fundamentally limit the
polarization states accessible by the EOM and would reduce confidence in the recovered
values of the Fourier coefficients. From a practical standpoint, the presence of two
harmonics (, 2) in the polarization-dependent response would require two LIAs per
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channel across three channels. Maintaining simultaneous calibration between each LIA
could prove challenging. Finally, uncertainty (bandwidth) in the frequencies recovered
via LIA is inversely proportional to the data acquisition time – e.g., longer acquisition
times allow increased confidence in the frequencies recovered via LIA. With integration
times as short as 150 ns for pixels near the center of a NOSE image (resonant mirror is
moving the fastest), this corresponds to a broad (~7 MHz) bandwidth in the LIA, which
would yield increased uncertainties in the recovered polynomial coefficients.
Both the naproxen crystals and the two crystalline domains of glucose isomerase
exhibited large variations in polarization response as a function of crystallographic
orientation. It is also of note that the net polarization response of naproxen appears to
differ from the net polarization response of glucose isomerase. For the horizontal SHG
channel, the naproxen color-map contains largely red, green and purple, whereas the
glucose isomerase 3D colormap contains crystalline domains of cyan and magenta. This
difference between samples suggests not only the ability to distinguish between
differently oriented crystals, but also between different types of crystalline materials.
This shows promise in the area of API polymorph screening, in cases where full
orientation mapping and therefore full NOSE analysis may not possible.

5.5 Conclusions
The theoretical framework for SHG ellipsometric microscopy has been presented
and experimentally verified. By incorporating fast polarization modulation with
synchronous digitization, it has been shown to provide a substantial reduction in
acquisition time as compared to previous NOSE techniques without significant loss in
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precision, allowing for real-time imaging applications. Validation of the technique and
instrumentation was performed using z-cut quartz with well characterized NLO
properties as a reference. The experimentally measured Jones tensor elements for z-cut
quartz fell within error of the theoretical predicted values. The technique was further used
to explore naproxen and glucose isomerase crystals with the resulting Fourier coefficient
images showing substantial differences due to crystal orientation. Furthermore, the
Fourier coefficient maps of naproxen as compared to glucose isomerase crystals
demonstrate an overall net coefficient difference allowing for not only differentiation of
crystal orientation but also differentiation of varying crystalline material. Lastly, it was
demonstrated that by coupling fast polarization modulation synchronously with detection,
the signal-to-noise of the measurement was sufficient to perform real-time (15 Hz)
polarization-dependent imaging with as little as 150 ns per pixel integration time and still
recover statistically significant Fourier coefficients directly connected to the tensors
defining linear and nonlinear properties of the sample.

82
5.6 References
(1)

Boyd, R. W. Nonlinear Optics, 2nd ed.; Academic Press: Amsterdam, 2003.

(2)

Campagnola, P. J.; Millard, A. C.; Terasaki, M.; Hoppe, P. E.; Malone, C. J.;
Mohler, W. A. Biophys. J. 2002, 81, 493–508.

(3)

Stoller, P.; Reiser, K. M.; Celliers, P. M.; Rubenchik, A. M. Biophys. J. 2002, 82
(6), 3330–3342.

(4)

Gusachenko, I.; Tran, V.; Houssen, Y. G.; Allain, J. M.; Schanne-Klein, M. C.
Biophys. J. 2012, 102 (9), 2220–2229.

(5)

Moreaux, L.; Sandre, O.; Mertz, J. J. Opt. Soc. Am. B 2000, 17 (10), 1685.

(6)

Plotnikov, S. V; Millard, A. C.; Campagnola, P. J.; Mohler, W. a. Biophys. J.
2006, 90 (2), 693–703.

(7)

Brasselet, S. Adv. Opt. Photonics 2011, 3 (3), 205.

(8)

Lin, S.-J. J.; Jee, S.-H. H.; Kuo, C.-J. J.; Wu, R.-J. J.; Lin, W.-C. C.; Chen, J.-S. S.;
Liao, Y.-H. H.; Hsu, C.-J. J.; Tsai, T.-F. F.; Chen, Y.-F. F.; Dong, C.-Y. Y. Opt
Lett 2006, 31 (18), 2756–2758.

(9)

Le, T. T.; Langohr, I. M.; Locker, M. J.; Sturek, M.; Cheng, J.-X. J. Biomed. Opt.
2007, 12 (5), 054007.

(10) Latour, G.; Gusachenko, I.; Kowalczuk, L.; Lamarre, I.; Schanne-Klein, M.
Biomed. Opt. Express 2012, 3 (1), 1.
(11) Brasselet, S.; Zyss, J.; R., C. Physique 2007, 8, 165.
(12) Sandeau, N.; Le Xuan, L.; Chauvat, D.; Zhou, C.; Roch, J.-F.; Brasselet, S. Opt.
Express 2007, 15 (24), 16051.
(13) Azhad U. Chowdhury Shane Z. Sullivan, Shijie Zhang, Kevin T. Jacobs, David J.
Kissick, Thora Maltais, Hartmut G. Hedderich, Patricia A. Bishop, and Garth J.
Simpson, C. M. D. J. Am. Chem. Soc. 2014, 136 (6), 2404–2412.
(14) E. L. DeWalt J. A. Ronau, S. Z. Sullivan, C. Das, G. J. Simpson, V. J. B. Acta.
Cryst. 2013, D69, 74–81.
(15)

Begue, N. J.; Simpson, G. J. Anal. Chem. 2010, 82, 559–566.

(16) Anceau, C.; Brasselet, S.; Zyss, J. Chem. Phys. Lett. 2005, 411 (1-3), 98–102.
(17)

Begue, N. J.; Moad, A. J.; Simpson, G. J. J. Phys. Chem. C 2009, 113 (23), 10158–
10165.

83
(18) Tanaka, Y.; Hase, E.; Fukushima, S.; Ogura, Y.; Yamashita, T.; Hirao, T.; Araki,
T.; Yasui, T. Biomed. Opt. Express 2014, 5 (4), 1099–1113.
(19) Lien, C.-H.; Tilbury, K.; Chen, S.-J.; Campagnola, P. J. Biomed. Opt. Express
2013, 4 (10), 1991–2002.
(20) Begue, N. J.; Everly, R. M.; Hall, V. J.; Haupert, L.; Simpson, G. J. J. Phys. Chem.
C 2009, 113 (23), 10166–10175.
(21)

Dettmar, C. M.; Simpson, G. J. In Second Harmonic Generation Imaging; Pavone,
F. S., Campagnola, P. J., Eds.; CRC Press: Boca Raton, FL, 2013; p 3.

(22) Plocinik, R. M.; Everly, R. M.; Moad, A. J.; Simpson, G. J. Phys. Rev. B Condens. Matter Mater. Phys. 2005, 72 (12), 1–14.
(23) Kissick, D. J.; Muir, R. D.; Sullivan, S. Z.; Oglesbee, R. A.; Simpson, G. J. 2013;
Vol. 8657, p 86570E – 86570E – 7.
(24) Muir, R. D.; Sullivan, S. Z.; Oglesbee, R. A.; Simpson, G. J. Rev. Sci. Instrum.
2014, 85 (3), 033703.
(25) Robinson, P. B. Data Reduction and Error Analysis for the Physical Sciences, 3rd
ed.; McGraw-Hill: New York, 2002.
(26)

Yeates, T. O.; Fam, B. C. Structure. 1999, pp R25–R29.

(27) Polizzi, M. A.; Plocinik, R. M.; Garth, J. 2005, 42833.
(28) Plocinik, R. M.; Simpson, G. J. Anal. Chim. Acta 2003, 496 (1-2), 133–142.
(29) Dehen, C. J.; Everly, R. M.; Plocinik, R. M.; Hedderich, H. G.; Simpson, G. J.
Rev. Sci. Instrum. 2007, 78 (1).

84
Table 5.1 Jones vectors for a variety of polarization states
Polarization

Jones Vector

Linearly Polarized: Vertical

1
0

Linearly Polarized: Horizontal

0
1

Linearly Polarized: +45°
Linearly Polarized: -45°
Circularly Polarized: Left
Circularly Polarized: Right

1 1
√2 1
1

1
√2 1
1

1

√2
1 1
√2

Illustration
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Table 5.2 Jones matrices for a variety of common optical elements
Optical Element

Jones Matrix

Linear Polarizer: Passing Vertical

1 0
0 0

Linear
Polarizer:
Horizontal

0 0
0 1

Passing

Linear Polarizer: Passing ±45°
Quarter Wave Plate (fast axis
vertical)
Half Wave Plate (fast axis vertical
or horizontal)

1 1
2 1

1
1

1
0

0

1
0

0
1
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Table 5.3 Experimental and theoretical Jones tensor elements for Z-cut quartz
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Figure 5.1 Instrument and timing schematic for a SHG and laser transmittance
microscope capable of synchronous polarization modulation. The master clock for
controlling the scanning mirrors and for data acquisition is provided by the laser,
originally an 80 MHz signal, divided by 8 to generate a 10 MHz clock.
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Figure 5.2 Characterization of the EOM response. Nonlinear fitting of A) horizontally
polarized transmitted fundamental beam and B) horizontally polarized SHG for z-cut
quartz rotated to 30 degrees and C) the EOM phase, Δ, as determined from the two
nonlinear fits. The Δ values for horizontal (H), vertical (V) and left-circularly
polarizations are also indicated. The relationship of Δ as a function of time is
demonstrated in D) for nonlinear fitting of laser transmittance.
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Figure 5.3 Experimental and theoretical normalized Fourier coefficients a and b for the
vertical and horizontal SHG detectors as a function of rotation angle for z-cut quartz.
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Figure 5.4 Summary of polarization-modulation SHG results for naproxen crystals for the
horizontal PMT. An overall intensity image a) and the same image separated out into its
10 unique polarization-dependent images b) are shown. The five Fourier coefficient
images are shown in c), with each coefficient representing a unique color (red, green,
blue, cyan and magenta for coefficients a, b, c, d and e , respectively). The five
coefficient images were then merged into a single 5-color image, shown in d).
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Figure 5.5 Images of a multidomain glucose isomerase crystal. A 2D laser transmittance
image of a multidomain glucose isomerase crystal integrated for all 10 polarizations is
shown in a). Corresponding 3D PCA (principal component 2) and Fourier coefficient
false color images are shown for the horizontal SHG detector in b) and c) respectively.
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CHAPTER 6. RAPID DISCRIMINATION OF POLYMORPHIC CRYSTAL FORMS
BY NONLINEAR OPTICAL STOKES ELLIPSOMETRIC MICROSCOPY

6.1 Introduction
Polymorphism, or the presence of multiple crystal forms for a single molecular
building block, is an important characteristic in the development of therapeutic small
molecules.1–5 As different polymorphs and crystal forms can exhibit widely varying
physiochemical properties, including overall formulation stability and drug solubility,
precise control over crystal form can be critical for reliable drug performance and product
quality control.1,2,6–8 Additionally, a thorough characterization of generally accessible
polymorph and cocrystal forms is typically performed prior to establishing intellectual
property rights on pharmaceutical formulations.9,10 The importance of control over drug
polymorphic form is perhaps best illustrated by the 1998 recall of Norvir® (oral capsule
formulation of the HIV protease inhibitor ritonavir) upon discovery of a more
thermodynamically stable polymorphic form with decreased oral bioavailability.11 As a
result of these motivations, drug development laboratories spend considerable resources
on discovering and characterizing the polymorphic forms of an emerging active
pharmaceutical ingredient (API).12–14
Trends in the pharmaceutical industry are shifting crystal form analysis to earlier
stages in the pipelines, targeting analysis of a greater diversity of samples to test with
ever smaller quantities of available purified product available for testing. High-
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throughput (HT) crystallization procedures intended to empirically map polymorphic
space for a new drug candidate are playing an increasingly important role in new form
discovery.8,15–17 While the parallel approach of HT crystallization technology offers an
overall time savings over traditional serial “batch” approaches, the characterization of all
crystal forms within multi-well plate crystallizations represents a non-trivial
measurement task as the available mass of purified materials are reduced. Techniques
such as Raman spectroscopy,18–21 Fourier transform infrared spectroscopy (FT-IR),22
powder X-ray diffraction (PXRD),16,18,20,23 differential scanning calorimetry (DSC),18 and
optical microscopy8,16,20 are currently used to assess the polymorphic form of hits.
Unfortunately, the time required for characterization by these methods creates a
bottleneck in the screening process that is ultimately limiting the number of screenable
conditions. While Raman spectroscopy generally provides shorter characterization times
(a few sec/measurement)20 relative to other techniques such as PXRD (current state of the
art requires ~60 sec/ measurement using benchtop systems)16, the overall time required to
analyze the results of several thousand crystallization experiments routinely exceeds the
number of trials that can be prepared and run. This disparity is often compounded by the
need for characterization by more than one analytical method, such that completion of a
HT study for a new drug candidate can take several weeks to complete.8 The analysis of
already known crystal forms may occupy a large portion of this characterization time.
Furthermore, the existing measurement time bottleneck is only likely to pose even greater
challenges for throughput as the decreased crystal mass in each well in high-throughput
screens lowers the overall SNR in the measurements. Additionally, preferred orientation
effects become increasingly important in small samples as the finite set of crystals results
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in a stochastic set of discrete crystal orientations.24,25 Preferred orientation can
significantly complicate automated analysis of the observed spectra;8 rotation is a
nonlinear operation, such that the measured Raman spectra and XRD patterns produced
from non-representative sampling generally cannot be expressed as simple linear
combinations of pure components. As a result, linear decomposition methods of the
spectra such as principal component analysis and linear discriminant analysis are often
intractable. A need has thus emerged for additional complementary characterization
approaches that can decrease characterization times from trace quantities of material in
HT new crystal form discovery.
Second harmonic generation (SHG) has been suggested as an alternative method
for crystal polymorph determination. In studies by Rades et al., differences in the angledependent SHG scattering were linked to changes in crystal form.26 However, the
discriminatory capability of conventional powder analysis by SHG is limited primarily to
differences in the overall intensity produced by a powder,27,28 which provides fairly small
discriminatory capability, requires sufficiently large samples to provide representative
sampling as in XRD and Raman, and is highly dependent on crystal size effects.29,30
Nonlinear optical Stokes ellipsometry (NOSE), combining rapid (8 MHz) polarization
modulation of the incident beam and polarized detection of the second harmonic, has
recently been shown as a measurement technique sensitive to both small molecule crystal
form and orientation ,31–33 increasing the information content of previous SHG
microscopy studies.34 This technique has the potential to alleviate measurement
bottlenecks found in HT crystallization studies through the Boolean discrimination and
subsequent removal of already-discovered crystal forms from more time-consuming
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analysis pipelines. Because NOSE is based on polarization-dependent measurements, it
has self-referencing measurement advantages over SHG measurements based on intensity
alone. Additionally, recovery of individual crystal orientations by NOSE microscopy
allows tensor analysis in the local-frame of the crystal, such that crystal form
determination can potentially be achieved even in samples containing only a handful of
microcrystals. Polymorphic analysis by NOSE has the additional potential advantages of
being fast (approaching video-rate) and non-destructive. Combining NOSE with
birefringence and traditional optical microscopy all acquired simultaneously on one
platform also opens up the possibility for the combination of multimodal analyses.
Here, we assess the potential merits of NOSE for rapid crystal form
discrimination using two polymorphic forms of the small molecule D-mannitol. Dmannitol was selected as a model system for several reasons. First, several polymorphic
forms are readily accessible via simple room-temperature recrystallizations.35
Additionally, D-mannitol is an exceedingly common small-molecule excipient used in
pharmaceutical formulations. Disentanglement of crystal structure and orientation allows
the recovery of local (crystal) frame nonlinear optical tensor elements describing the
polarization-dependent SHG efficiency for a given crystal. These unique tensor elements
serve as the experimental observable for discrimination on a per-crystal basis. Polymorph
discrimination based on NOSE is shown for orthorhombic (P212121) and monoclinic
(P21) structures of D-mannitol. The potential for discrimination was assessed from
measurements of only ~1 g of material, consistent with compatibility with small volume
HT crystallization studies.
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6.2 Materials and Methods

6.2.1 Experimental
D-Mannitol was purchased from Sigma-Aldrich. Orthorhombic and monoclinic
forms of D-mannitol were crystallized from different solvents according to previously
published protocols.36,37 The orthorhombic form was recrystallized from 70/30
ethanol/water, and the monoclinic form was obtained via an anti-solvent crystallization
from 50/50 water/acetone. Powder X-ray diffraction (PXRD) patterns were obtained on a
Rigaku SmartLab® X-ray diffractometer, using a wavelength of 1.554 angstroms and a
scan speed of 0.6 2/min. Acquired PXRD patterns were compared to those predicted by
Mercury® (Cambridge Structural Database, CSD).38 Entry IDs of CSD entries were
DMANTL8 (orthorhombic) and DMANTL14 (monoclinic).
NOSE images were required on a custom microscope capable of 8 MHz
polarization modulation described in detail in several previous publications.31,33 In brief,
an 800 nm, 80 MHz, 100 fs Ti:sapphire laser (SpectraPhysics) at an average incident
power of 200 mW was used as the light source, and focused onto the sample using a 10x,
0.3 NA objective (Nikon). The laser serves as the master clock for the beam-scanning and
data acquisition electronics. The microscope utilizes a resonant mirror (~8 KHz, EOPC)/
galvanometer mirror (CambridgeTech) for beam scanning and PCI express digital
oscilloscope cards (AlazarTech) as the ADC. SHG is separated from the fundamental via
a series of dichroic/ band-pass optical filters, and photomultiplier tubes (PMT)
(Hamamatsu) are used as detectors. An electro-optic modulator (EOM) is used for

97
polarization modulation at 8 MHz (laser serves as master clock), and is oriented at +45
from its fast axis. Glan-Taylor polarizers (GTs) were placed before the two PMTs
(transmission direction), with a quarter wave plate (QWP) oriented at +22.5 placed after
the sample, prior to the polarizer. A GT was also placed before a photodiode
(transmission direction) to allow polarized detection of the laser fundamental.

6.2.2 Computational
Following image acquisition, OrientationJ (NIH ImageJ) and custom Matlab
software were used for analysis. ImageJ was used to threshold the SHG images, allowing
particle (crystal) analysis. The SHG intensity for each input polarization was averaged
across each individual crystal. The ten polarization-dependent responses are then
contracted down to a set of five Fourier coefficients via linear least-squares fitting
(Matlab) as described previously.31 These Fourier coefficients are a function of both
sample orientation (described by Euler angles , , and ) and intrinsic polarizationdependent nonlinear optical susceptibility. A custom iterative, nonlinear least-squares
fitting algorithm was developed for the analysis of NOSE images. This algorithm has
been described in detail in related publications,32,33 and recovers two unknown orientation
angles (, ), the per-crystal SHG intensity, and the values of the local-frame nonlinear
optical susceptibility tensor elements. For each crystal in the image (particles identified
via ImageJ), the in-plane azimuthal rotation angle () was measured with the OrientationJ
plug-in (NIH ImageJ).
Following conversion of the Fourier coefficients to an alternative set of
polynomial coefficients, the coefficients and in-plane orientation angles for each crystal
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were used as inputs into the iterative fitting algorithm. In the first step, a user-defined set
of local-frame nonlinear optical susceptibility tensor elements and the in-plane
orientation angle (recovered from OrientationJ) were assumed, and a nonlinear leastsquares fit of the polynomial coefficients to recover the remaining two orientation angles
and the per-crystal SHG intensity was performed. Following completion of the fit, the
obtained values for , , and the per-crystal SHG intensity were assumed explicitly, and
an additional nonlinear least-squares fit to recover local-frame tensor element values
(constrained fit) was then performed. This entire process was iterated until the system
converged. As described in the related publications,32,33 the algorithm has been validated
on both theoretical data of multiple symmetries and thinly-sectioned porcine/ mouse
collagenous tissue samples. Due to sensitivity of the recovered orientation angles on
initial parameter guess values (i.e., equivalent solutions are found), the iterative algorithm
was subjected to 100 independent runs with randomized guess values for  and . The
mode of the recovered values for the local-frame tensor elements and orientation angles
for each crystal was used for subsequent analysis.
The symmetry properties of the D-mannitol structures studied herein yield 3 and
13 unique non-zero tensor elements for the orthorhombic (P212121) and monoclinic (P21)
structures, respectively. Together with 2 orientation angles this yields 5 and 15 recovered
variables, respectively, for the measurement. As the number of recovered parameters for
the P21 structure exceeds the number of observables, direct recovery of all unique nonzero tensor elements for the monoclinic form is not anticipated to be accurate (high
covariance) and was thus not attempted. However, the goal of this study is simply
Boolean discrimination of orthorhombic structures for the purpose of identifying a
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common crystal form. Accordingly, NOSE measurements of both the monoclinic and
orthorhombic crystal structures were fit to the equations describing the orthorhombic
response to recover 3 unique local-frame tensor elements (along with per-crystal SHG
intensities and two orientation angles) for each crystal structure. Following 2-class linear
discriminant analysis (LDA) for optimal dimension reduction, statistical tests (F test and t
test) were then used to provide a quantitative means of making the Boolean structure
discrimination through comparison of the probability density functions (pdfs) giving rise
to the responses for the “known” form (orthorhombic) and the “unknown” form
(monoclinic).

6.3 Results and Discussion
D-Mannitol was crystallized into two polymorphic forms via recrystallization
from common solvents. These two forms adopt orthorhombic (P212121) and monoclinic
(P21) symmetries. Confirmation of the two crystal structures was performed via PXRD.
Figure 1 contains the observed diffraction data together with the predicted patterns from
the Cambridge Structural Database (CSD)38 for both the orthorhombic (CSD ID
DMANTL8) and monoclinic (CSD ID DMANTL14) crystal forms, based on the reported
lattice constants and nuclear electron densities. Although there are some disparities in the
relative peak heights, excellent agreement between most 2 diffraction angles is
generally observed.
NOSE colormaps of orthorhombic (left column) and monoclinic (right column)
forms of D-mannitol are shown in Figure 2 for both the horizontally polarized PMT (H
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PMT) and the vertically polarized PMT (V PMT). NOSE colormaps are created through
linear fitting of the n-polarized SHG intensities to a set of five Fourier coefficients as
described previously and shown in Equation 1.

I n2  an  bn cos(2 )  cn cos( )  d n sin( )  en sin(2 )

6.1

The polarization state of the incident light emerging from the EOM is dependent on the
phase shift  in Equation 1, with the values of a-e Fourier coefficients shown as merged
red, green, blue, cyan, magenta (RGBCM) images in Figure 2. The relative magnitude of
each coefficient (a,b,c,d,e) provides the color weighting (RGBCM, respectively) within
each pixel of the image. These images thus contain all polarization-dependent NLO
information recovered from the measurement. As described previously,31 further analyses
are performed following linear conversion of the above Fourier coefficients to an
alternative set of polynomial coefficients. While the images shown in Figure 2 were
obtained through linear fitting on a per-pixel basis for ease in visualization, the
subsequent data analysis presented herein involved linear fitting after averaging the
polarization-dependent SHG response across each individual crystal. The amplitudes of
the Fourier coefficients depend upon both the inherent polarization-dependent SHG
activity and the orientation of each crystal within the field of view. The inherent
polarization-dependent SHG activity for a crystal is described by a rank 3 tensor, where
each scalar entry describes the efficiency and relative phase of frequency doubling given
defined polarizations for both the incident and exiting fields. SHG expressed in the local
Cartesian frame for the crystal can yield as many as 18 unique non-zero tensor elements
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for a material. However, many of these tensor elements are equal or zero-valued by
symmetry, with higher symmetry materials containing more zero-valued entries.
The first method assessed for discrimination was based on statistical analysis of
the directly recovered Fourier coefficients. Two-class linear discriminant analysis (LDA)
was performed on these coefficients. These results are summarized in Figure 3.
Following projection onto the Fischer discriminant, histograms of the pooled response
from crystals of each structure were constructed to visually compare separation of the
probability density functions (pdfs). The data were also compared via a conventional F
test and t test to quantitatively assess statistical independence of the variances and means
(respectively) of the two experimental distributions. The t test is only performed if the
distributions first pass the F test, indicating that the variances in the compared data are
not statistically distinguishable with 99.99% confidence. Figure 3 shows a histogram of
the raw coefficients following LDA for the orthorhombic (blue) and monoclinic (red)
structures. Calculated values for the F and t tests are shown in Table 1 with green
indicating a pass and red indicating a failure of the test.
Two different contributions to the separation were considered; changes in the
polarization-dependence and differences in the orientation-corrected, per-crystal SHG
intensities. The raw coefficients giving rise to the histograms shown in Figure 3 vary in
response to changes in all of these quantities. To aid in understanding the role of the
orientation-corrected, per-crystal SHG intensities in driving the separation of these
distributions, the raw polynomial coefficients in Figure 3 were intensity-normalized
through division by the per-crystal intensity values found via the iterative, non-linear
least squares fitting algorithm. Figure 4a shows histograms of the projected coefficients
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after intensity-normalization. Additionally, histograms of these orientation-corrected
intensity values are shown directly in Figure 4b. Calculated F and t values are shown in
Table 1.
All statistical tests presented herein assume a 99.99% confidence interval. In
brief, the recovered distributions following LDA of the raw polynomial coefficients pass
the F test but fail the t test, indicating that the pdfs giving rise to these distributions have
statistically independent means within the 99.99% confidence interval. The intensitynormalized polynomial coefficients pass both the F and t tests (i.e., no statistically
significant discrimination at the given confidence interval can be achieved in either the
variance or the mean projected along the LDA axis). From inspection of the color-maps
(Figure 2), it is clear that in-plane orientation of the crystals contributes significantly to
the diversity of polarization-dependent responses observed in the laboratory frame.
To disentangle the effects of laboratory-frame crystal orientation from those of
inherent local-frame polarization dependence of the crystals, the above analyses were
repeated for the local-frame tensor elements obtained via the iterative, non-linear least
squares fitting algorithm. These results are summarized in Figures 5 and 6. Figure 5
shows histograms of the raw local-frame tensor elements obtained for each crystal
structure, with the calculated F value shown in Table 1. The orientation-corrected
intensities obtained via nonlinear least-squares analysis (Figure 4b) can also be included
when analyzing the distributions of the local-frame tensor elements. For visualization
purposes, a scatter plot showing the local-frame tensor elements for each crystal form
after multiplication by the per-crystal intensities recovered via the iterative nonlinear
least-squares analysis is given in Figure 6a. The larger variance of the monoclinic
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structures relative to the orthorhombic structures is readily observed. Figure 6b shows a
histogram of the data in 6a following LDA. The calculated F value for the distributions
shown in Figure 6b is also included in Table 1. Both the local-frame tensor elements and
the intensity-corrected local-frame tensor elements fail the F test, as summarized in Table
1.
Collectively, these tests yield information on the primary mechanisms responsible
for discrimination in NOSE microscopy measurements of crystal forms. The raw
polynomial coefficients, which contain both intensity and polarization information, pass
the F test but fail the t test following LDA. However, these data pass both the F and the t
tests and are statistically indistinguishable after removing the intensity information from
each set of polynomial coefficients on a per-crystal basis. When considering only
orientation-corrected, per-crystal SHG intensities and no polarization-dependent
information, the results from the two crystal forms fail the F test, indicating statistically
significant discrimination. These combined results are consistent with the disparity in
orientation-corrected, per-crystal SHG intensities between the two samples serving as the
primary discriminatory property when laboratory-frame polynomial coefficients are used
for the discrimination.
These results are also consistent with diverse crystal orientations being the next
most dominant mechanism dictating the value of the polynomial coefficients, suggesting
the potential for improved discrimination when using orientation-corrected local-frame
tensor elements instead of laboratory-frame polynomial coefficients. Consistent with this
expectation, the calculated F values following LDA of the derived local-frame tensor
elements are significantly higher (effectively infinite discrimination) than those found
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following LDA of the laboratory-frame polynomial coefficients. These results are
consistent with increased separation observed between the two structures once the
orientation-dependence of the nonlinear optical crystal response is removed. Fcalc for the
intensity-corrected local-frame tensor elements is greater than Fcalc for the raw localframe tensor elements. This increase indicates that the discriminatory capability is further
improved when combining both the orientation-corrected per-crystal SHG intensities and
the local-frame polarization-dependence. While orientation-corrected per-crystal SHG
intensity information alone may enable structure discrimination under the experimental
conditions in the present work, the confidence in that discrimination further improves
when also considering polarization-dependent effects. Considering hypothetical NOSE
measurements with lower SNR than in the present study, it is possible that discrimination
could be enabled when considering these combined observables, but not feasible when
considering only the orientation-corrected per-crystal SHG activities. It is also worth
noting that the scalar intensities found via the nonlinear fitting algorithm in the present
study differ from the scalar intensity quantities in previous works. Scalar intensities
found through single-point measurements on bulk powdered samples26–28 are sensitive
not only to crystal polymorphic form, but also to the presence or absence of phase
matching, the packing density, orientation distribution, and particle size distribution of
the sample. Several of these sources of ambiguity have been addressed in more recent
studies based on SHG microscopy of powders.39 In contrast, the single-crystal,
orientation-corrected intensities presented here-in have largely removed the dependence
on packing density, orientation, and phase-matching, further isolating the effects from
polymorphism on the overall SHG intensity.
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While the recovery of local-frame tensor elements was demonstrated for the
P212121 and P21 crystal classes in this work, this strategy can be generalized to other
crystal classes. Formally, the process of SHG is symmetry-allowed in any crystal lattice
without an inversion center (noncentrosymmetric). Thus, discrimination of crystal
structures by NOSE should in theory be possible under the simple constraint that all
crystal classes involved are noncentrosymmetric. The general ability of NOSE for
discriminating specific crystal classes is highly dependent on the differences in molecular
packing and orientation relative to the crystallographic coordinates, such that general
conclusions should be made cautiously. Fortunately, relatively simple molecular-level
calculations can provide reasonable estimates regarding the discriminatory capability of
NOSE. Previous work has demonstrated good correspondence between ab initio
predictions and experimental orientationally averaged SHG activities.40 It is reasonable to
expect similar reliability for prediction of the polarization-dependent differences between
unique crystal forms. The current experimental architecture yields limits on the number
of local-frame tensor elements recoverable via the iterative nonlinear least-squares
analysis. However, the addition of a quarter wave plate to the beam path (pre-sample) and
repetition of the data acquisition at multiple wave-plate rotations could provide additional
independent measurements and enable the recovery of a higher number of local-frame
tensor elements.
The use of NOSE for polymorph discrimination offers several other advantages
consistent with practical considerations in performing HT crystallization studies for
crystal form discovery. While the polymorphs were synthesized at a relative large (~g)
scale for ease of preparation, the actual microcrystalline mass used for discrimination is
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estimated to be approximately 1 g. This mass is consistent with per-well mass values
typically encountered in small-volume HT crystallization studies. Additionally, NOSE
imaging can be performed rapidly. Each FOV in the present study took approximately 7
seconds to acquire, although the observed SNR in the SHG images (~300) and high
confidence in the subsequent statistical tests suggests this acquisition time could be
significantly reduced. In any measurement, the limits of quantitation are always greater
than the limits of detection, including the present case. One of the key enabling
advantages of the NOSE measurement approach is dramatic reduction in the 1/f noise
produced in analogous wave plate-based measurements, such that significantly greater
confidence can be assigned with shorter measurement times. NOSE imaging at video
rates has been demonstrated previously.31 Additionally, while the two polymorphic forms
were kept physically separated to ease validation (e.g., PXRD) in this proof-of-concept
study, the analysis presented here (performed on a per-crystal basis) is readily applicable
to mixtures of polymorphic forms. Within the assumption that the individual crystals
within a multi-structure mixture could be prepared in a manner that minimizes physical
crystal overlap, the methodologies presented in this manuscript should directly enable
structure discrimination. Finally, it is worth emphasizing that the discrimination
demonstrated in this study is based solely on the SHG measurements alone. Additional
considerations such as crystal habit (e.g., needle, plate, etc.) could provide additional
complementary indicators for polymorphism discrimination based on image analysis.
Given that the SHG is expected to be largely independent of crystal habit, the two
methods should be largely orthogonal. Although not the primary subject of the present
study, additional discrimination capabilities are possible by combining the NOSE
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measurements with polarization-dependent laser transmittance microscopy, which is
performed concurrently with NOSE imaging. Bright field imaging is commonly used to
identify crystal formation (hits) and crystal structures/ habits in HT studies; the laser
transmittance images obtained in NOSE retain this imaging modality. Furthermore, the
polarized detection present on this channel allows recovery of observables describing
sample birefringence, another modality commonly used in the assessment of crystal
forms in HT studies. However, the polarization-dependent changes arising from
birefringence were generally relatively subtle compared to analysis by NOSE, and highly
dependent on the thickness of the crystals.
These collective results suggest the viability of NOSE for rapid polymorph
discrimination for fast pre-screening. This first study was limited to the discrimination of
two polymorphic forms. In principle, extension to systems exhibiting many accessible
polymorphic forms simply represents expansion to n-class LDA. In practice, the high
degree of discrimination achieved from recovery of the local-frame tensor elements and
intensities suggests optimism in generalization of this approach to higher numbers of
crystal forms.
The recovery of crystal orientation angles also has the potential to benefit analysis
of HT crystallizations by PXRD and Raman. In the event that an outlier is detected based
on NOSE microscopy as demonstrated herein, a natural next step would be to confirm or
refute by an orthogonal method such as PXRD or Raman. The limited number of crystals
typically found in modern solid form screens can complicate analysis by both methods
due to significant preferred orientation effects in the observed scattering patterns.24,25
Accounting for these effects through increased data acquisition (e.g., repeating the
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measurement at a variety of sample orientations) requires significant additional analysis
times. The crystal orientation information recovered through NOSE could potentially be
fed into these pipelines and used to correct for preferred orientation effects, helping to
alleviate these additional bottlenecks in crystal characterization. In this manner, NOSE
measurements may serve double-duty, first for identification of outliers and next to aid in
subsequent orthogonal analyses.

6.4 Conclusions
NOSE microscopy has been shown to allow highly confident (>99.99%)
discrimination of orthorhombic and monoclinic crystal forms of D-Mannitol in a few
seconds of total measurement time. Rapid (8 MHz) polarization modulation allows the
recovery of a set of polynomial coefficients for each sample at <7 seconds per FOV with
a SNR of ~300. These coefficients enabled discrimination directly, following two-class
LDA for dimension reduction. However, substantial improvements in discrimination
were achieved by correcting the polarization-dependent measurements for local crystal
orientation. Transformation of the polarization-dependent response to the local-frame
allowed direct recovery of the tensor elements for the P212121 crystal form and confident
detection of the P21 crystals that were not well described by those recovered local-frame
tensor elements. Furthermore, the complete analysis was performed using only ~1 g of
crystalline material. These collective results have the potential to help address bottlenecks
in HT crystallizations for therapeutic molecule polymorph discovery.
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Table 6.1 Summary of statistical tests. Green shading indicates a pass, red shading
indicates a failure. Ftable = 2.44 ttable = 3.69. *Denotes the assumption of a lognormal
distribution

System

Fcalc

tcalc

Raw Polynomial Coefficients

1.35

10.8

Intensity-Normalized Coefficients

1.18

~0

Per-crystal Intensities

2.61*

-

Raw Local-Frame Tensor Elements

14.4

-

Intensity-Corrected Tensor Elements

50.1

-
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Figure 6.1 Summary of PXRD results. Experimental (solid trace) and predicted (dotted
trace) PXRD patterns for orthorhombic (blue, bottom) and monoclinic (red, top) crystal
structures of D-mannitol. Patterns are artificially offset vertically for clarity. Predicted
patterns were obtained from the Cambridge Structural Database (CSD), entry IDs
DMANTL8 and DMANTL14, respectively. General agreement between the experimental
and theoretical 2 values and relative intensities was observed.

114

Figure 6.2 NOSE colormaps for two crystal structures of D-mannitol. Values of a-e from
equation 1 are shown as a merged RGBCM image for each of two photo detectors
(horizontally and vertically polarized PMTs). The values of a-e collectively describe all
polarization-dependent nonlinear optical properties of the sample, including the
combined effects of both inherent polarization-dependent SHG activity and crystal
orientation within the field of view.
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Figure 6.3 Histograms following two-class linear discriminant analysis of the raw
polynomial coefficients for orthorhombic (blue) and monoclinic (red) forms of DMannitol. The means of the recovered distributions fail a t test with >99.99% confidence.
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Figure 6.4 Histograms for the intensity-normalized polynomial coefficients following
LDA (A) and for the raw intensities obtained from the iterative nonlinear least-squares
fitting algorithm (B). The distributions in (A) pass both the F test and the t test, while the
distributions in (B) fail the F test. These results are consistent with the orientationcorrected, per-crystal SHG intensities being the primary mechanism enabling
discrimination of the orthorhombic (blue) and monoclinic (red) crystal
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Figure 6.5 Histograms of the raw local-frame tensor elements following LDA for
orthorhombic (blue) and monoclinic (red) forms of D-Mannitol. The recovered
distributions fail the F test with >99.99% confidence.
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Figure 6.6 Raw data and histograms for the intensity-corrected local-frame tensor
elements. Scatter plot (A) and histograms following LDA (B) for orthorhombic (blue)
and monoclinic (red) forms of D-Mannitol. The scatter plot in (A) allows direct
visualization of the increased variance in the intensity-corrected local-frame tenor
elements observed for the monoclinic structures relative to orthorhombic structures. The
distributions shown in (B) fail the F test.
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CHAPTER 7. DIGITAL DECONVOLUTION FILTER DERIVED FROM LINEAR
DISCRIMINANT ANALYSIS AND APPLICATION FOR MULTIPHOTON
FLUORESCENCE MICROSCOPY

7.1 Introduction
Accurate quantitation of optical signals in NLO microscopies is necessary to
preserve the signal to noise (SNR) advantages of the measurement approaches discussed
in previous chapters. For measurements based on photon counting, saturation of the
detector (e.g., a photomultiplier tube) can severely limit the linear dynamic range of the
measurement. This problem is of particular interest in SHG/ TPE-UVF images of APIs,
due to the 7-decade range of intrinsic API crystal brightness for both NLO processes.
Arguably the most common problem limiting the LDR of photon-counting measurements
is known as “pulse pile-up,” in which high photon flux rates cause overlapping response
peaks in the time-dependent voltage trace emerging from the photo-detector. In
traditional photon-counting methods, a count is recorded when the voltage vs. time trace
passes a pre-defined threshold on the rise. If two photons are either 1) time coincident or
2) closely spaced in time such that the voltage does not drop below the threshold before a
second event occurs, bias from undercounting arises. Accordingly, the maximum count
rate plateaus as photon flux increases.
A number of previous strategies have sought to increase the LDR of photoncounting measurements. One common approach is to operate multiple detectors in
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parallel, where the total photon flux is intentionally distributed among multiple channels,
decreasing the LDR required on a single channel.1–4 In addition to increasing costs, such
a strategy necessarily diminishes the SNR of the measurement. The use of multiple
detectors also increases the number of dark counts in the measurement, potentially
increasing limits of detection. Another method relies on imposing a “dead time”
following a counting event, whereby the signal is intentionally neglected for a short
period time following a count to allow the voltage to return below the threshold before
another count can be recorded.5 Known as paralysis, this technique can be effective at
low count rates, but may increase data acquisition times and has a limited LDR.
Techniques to increase the LDR of counting measurements based on curve-fitting
have also been demonstrated.2,6–9 Such strategies often rely on prior knowledge of the
impulse response function, where the peak temporal location and height can be recovered
through curve fitting of the raw voltage vs. time data. While effective for the recovery of
accurate count rates,10–13 such strategies are generally time-consuming in their
implementation, particularly at high (> mega counts per second, Mcps) count rates as are
often encountered in NLO microscopy (a curve fit is required at every data point).
New strategies based on deconvolution of the instrument response function (IRF)
from the raw voltage vs. time data could have the potential to increase the LDR of
photon-counting measurements. If a temporal impulse could be recovered from the raw
data, pulse pile-up may be largely avoided, as voltage transient life time is dramatically
reduced.14 For raw data emerging from the analog to digital converter (ADC), digital
filtering is an attractive option for deconvolution due to its speed and relative simplicity.
Weiner-type digital filters, intended to deconvolve the IRF from the raw data, have been
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widely used for this purpose. While successful when the IRF is known a priori, Wienertype filters do not perform as well when the IRF is an unknown form or when
measurement noise is not normally distributed.
In the present study, a novel digital filter developed from linear discriminant
analysis (LDA) is presented. The filter is generated by finding the optimal axis of
separation for time-coincident (class 1) and time non-coincident (class 2) voltage
transients. Following training for generation of the filter, the performance of the filter
was tested via simulations at a variety of photon flux rates and noise levels. The
algorithm was also used to correct for a complex IRF in two-photon UV fluorescence
images containing significant ringing in the voltage transients. Complementary
simulations with the same ringing IRF showed the ability of the algorithm to extend the
linear dynamic range of the measurement by over an order of magnitude relative to other
approaches.

7.2 Theoretical Foundation
Digital filtering is a common technique with a variety of applications in signal
processing. Here, digital filtering is performed in the time domain via convolution of the
filter function with the time-domain raw data. The process of digital filtering for discrete
signals is shown in Figure 7.1. A model voltage transient representing an exponentially
decaying IRF is shown in blue, and the digital filter is shown in red. Filtering through
convolution of the data and the filter is performed by a sliding dot product, in which the
scalar output replaces the data point coincident with the center (origin) of the filter. The
filtered output is shown in green in Figure 7.1 (offset horizontally for clarity).
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The digital filter used here-in seeks the recovery of a sharp temporal impulse
through deconvolution of the IRF, and is generated via 2-class LDA. LDA is a supervised
multivariate method of data analysis for the separation of data into distinct groups. The
two classes used for training the digital filter are time coincident and non-coincident
voltage transients, in which the peaks either overlap temporally with the center (origin) of
the filter or are randomly shifted in time, respectively. Voltage transients for each class
are shown in Figure 7.2, with coincident transients shown in red and non-coincident
transients shown in blue. The digital filter and the projection of the two classes in filter
space are also shown. Defining the two classes for LDA in this way creates a filter
(projection axis) that maximizes the resolution between voltage transients that are
centered at the filter origin (class 1) and any temporally neighboring transient (class 2).
Mathematically, it is the scalar value of the Fisher discriminant15 that is maximized
according to the following equation:

   

J  w   c2 n2
sc  sn

2

7.1


Where w is the direction within voltage transient space the provides maximum

separation between the two classes. Here, c and n correspond to the projected (scalar)
values of the average voltage transients from each class, and sc and sn are the projected

variances for each class. The axis w is found through solving the eigenvector-eigenvalue

equation shown below.
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Where the matrices SW and S B represent the within and between class variance
(respectively), and are given by the equations below
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With an analogous expression for SWn (not shown). xi indicates the ith vector from the

relevant class ( Nc total vectors in the coincident class, “c”), and c is the average vector

from class c. The vector w serves directly as the filter function, F.
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When the origin of the filter (typically the center) is time-coincident with the onset of the
transient, the scalar output of the filter is given by the dot product of the filter with the
transient. Analogously, application of the filter function in a non-coincident position will
correspond to a projection of the non-coincident class. Consequently, convolution of the
time-trace by the digital filter F generated by LDA maximizes the contrast between
coincident and non-coincident events to optimally recover deconvolved -function
(impulse) single-pixel maxima at the location of the transient onsets.
Following application of the LDA-based digital filter, a conventional high pass
(HP) filter is used to remove rolling background features introduced by the LDA-based
filter. In practice, these two filters may be combined (convolved) to enable single step
LDA and HP filtering. Subsequently, traditional threshold-based counting is performed,
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in which a count is registered with the data trace crosses and arbitrary threshold on the
rise.

7.3 Materials and Methods
Simulations with known ground-truth results were performed to assess the
performance of LDA-derived digital filtering relative to both conventional photon
counting and signal averaging. To produce the training sets, each photon generated a
random peak height corresponding to a lognormal distribution in gain in the PMT. A
mean µL of 7 mV and standard deviation L of 4 mV describing the lognormal
distribution were selected based on measured characteristics for PMTs similar to those
used in the present study. The temporal impulse response was also approximated by a
lognormal function. For the coincident training set, the initial onset of the pulse was
assumed to be at time zero in the center of the filter. The non-coincident training set was
generated by offsetting the initial onset by normally distributed random shifts . Each
trial also included addition of random 1/f noise, generated by Fourier transformation of
normally distributed time-trace, multiplication by

1⁄

, in which f is the

frequency and b = 0.005 is a constant describing the time-scale for 1/f fluctuations,
followed by inverse Fourier transformation to recover a time-trace. Qualitatively similar
results were observed with normally distributed random noise.
In the simulations of the experimental data acquisition, each time-point contained
a Poisson-distributed random number of photons, where  was the mean of the Poisson
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distribution (typically less than 1). The time-traces also included 1/f noise calculated
identically as the simulated data used to generate the training sets.
The probability of two or more photons arriving within a single time-step
becomes non-negligible as the mean of the Poisson distribution approaches unity, which
can introduce additional bias not accounted for directly by deconvolution alone. The
LDA-filtering approach is designed to maximize the separation between transients
produced at separations of more than one time-step of the digitizer, and will therefore not
be able to correct for the recording of a single count from two or more simultaneous
photons. Fortunately, this source of bias can be corrected by connecting the measured
counts (distributed according to a binomial distribution, with only two possible
outcomes) to the underlying number of photons described by a Poisson distribution.
Using algorithms developed previously,10,11 the mean  and standard deviation  of the
Poisson distribution in a given t time window are given below, where p is the mean
probability for successful counting and N is the number of measured time-points used to
assess the mean.

  ln 1  p 

7.6

p
e  1
 

N 1  p 
N

7.7

2

For a sufficiently large number of measurements, the experimental mean of p
provides a reasonable estimate for the true mean of p, from which the mean and standard
deviation of the underlying Poisson distribution can be determined through Equations 5
and 6.
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Two –photon excited ultraviolet fluorescence (TPE-UVF) images of pure Ltryptophan crystals (Sigma- Aldrich) were acquired using a custom microscope. Briefly,
a Fianium Inc, ultrafast fiber laser (1060 nm, 150fs, 80MHz) output was doubled to
generate 530 nm, which served as the incident light source for TPE-UVF excitation. The
incident beam was scanned along the fast axis using a resonant vibrating mirror (~4 kHz)
and along the slow axis using a galvanometer mirror. The scanned beam was directed
through an inverted Nikon microscope (TE2000) through telocentric lens pairs and
dichroic mirrors and focused onto the sample using a 10X objective (Nikon), as described
previously TPE-UVF signal was split into its horizontal and vertical components using a
Glan-Taylor polarizer, both of which were detected on two separate photomultiplier tubes
(PMTs) in the reflected direction. TPE-UVF signal was passed through a filter stack (440
nm high pass and 532 nm high pass filters, Semrock) to reject the fundamental 530 nm
light and pass two-photon tryptophan emission (~350 nm). The voltage transients from
the photomultiplier tubes were flash digitized using oscilloscope cards from AlazarTech
(ATS 9462) at 80MHz, with the laser providing the master clock to the digitizer cards. To
artificially produce a noisy ringing transient, the oscilloscope cards were set to an internal
impedance of 1 MΩ and the PMT with a nominal impedance of 50 Ω was connected to
the oscilloscope cards with a 20m long cable and a 400 Ω resistor in parallel at the
oscilloscope card input.
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7.4 Results and Discussion
The LDA-based digital filter was trained using two sets (classes) of 6000 voltage
transients each (time coincident and non-coincident). Example voltage transients for each
class, the derived filter, and the projection of each training set in filter space are shown in
Figure 7.2. Simulations of the performance of the filter were performed across a variety
of photon flux levels, expressed as the mean of the Poisson distribution (). For these
simulated data, the ground truth temporal locations of photon arrival times are known a
priori, allowing assessment of the performance of the filter through identification of false
positives/ false negatives. Figure 7.3 shows the performance of the filter across three
values of . The distinct photon events are easily discernable by eye in each data trace,
although simple threshold-based counting is likely to miss photon events in the middle
(=0.05) and bottom (=0.10) data traces due to pulse pile up. The data trace following
LDA + HP filtering is shown in blue, and the counting threshold is shown in green.
Photon counting of the filtered data correctly recovered all photons with zero false
positives for the each data trace shown (pink bars).
The effects of threshold position can be assessed via a receiver operating
characteristic (ROC) curve, in which the true positive rate is plotted against the false
positive rate at for a variety of threshold settings, as shown in Figure 7.4. Curves at
multiple values of  are shown. An optimal measurement (maximized true positives and
minimized false positives) would appear as a data point at the upper left of the plot. The
shifting of the curve away from the upper left corner as  increases is expected, as pulse
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pile-up becomes more likely. However, the algorithm still performs well (~80% true
positive rate) even at incredibly high ( = 0.4) photon fluxes.
Following these simulations, the performance of the filter was also assessed for
experimental data with a complex IRF by inducing ringing effects in the voltage
transient. This was accomplished through the inclusion of a 400  resistor in parallel
with the 1 M internal resistance of the digital oscilloscope card. By using a long (20 m)
transmission cable, a time delay between each reflection is introduced, yielding a ~700 ns
decay time in the IRF ring-down. An example of the ringing IRF is shown in Figure 7.5a.
Figure 7.5b shows the digital filter derived for this IRF after LDA. Raw data containing
the ringing IRF is shown in Figure 7.5c (red trace), along with data after LDA-based
filtering alone (green trace) and LDA + HP filtering (blue trace). The presence of two
distinct photon events is clear through visual inspection of the red trace (given the
waveform of an individual IRF shown in 7.5a.) The LDA + HP filtered data recovers
impulses at each of these time points, and has eliminated the ringing shown in the red
trace.
Two-photon ultraviolet fluorescence (TPE-UVF) images of tryptophan were
acquired under both normal conditions (50  termination) and with the ringing waveform
discussed above. These measurements were performed simultaneously through the use of
a polarizing beam-splitting cube after the sample, with two PMTs operating in parallel.
Figure 7.6a shows the TPE-UVF image of tryptophan from the impedance-matched
channel, while Figure 7.6b is the raw image obtained from the PMT with the ringing IRF.
Insets show raw time-domain data for each configuration. Inaccurately high counts in
Figure 7.6b are due to both 1) ringing in the single photon IRF and 2) compounded
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baseline drift due to pulse pile up given the ringing waveform. Both effects are seen in
the raw data within 7.6b. Figure 7.6c shows the image from 7.6b following digital highpass filtering to help correct for baseline drift. While closer to the ground truth (7.6a)
than 7.6b, the presence of ringing (data inset) yields inaccurately high count rates in
addition to a blurring of the image along the fast scan axis. Figure 7.6d shows the
recovered image following LDA + HP digital filtering. While the image retains some
blurring artifacts along the fast mirror axis, visual inspection shows significant
improvement relative to 7.6c. Additionally, the data inset shows the removal of the
ringing waveform following application of the digital filter.
The presence of two peaks of opposite sign and disparate magnitude in the LDAderived digital filter (Figure 7.5b) yields insight into the likely mechanism of action of
the filter. The relative magnitudes of the two peaks in the filter function likely work to
give a near-zero dot product when overlapped with most peaks in the ringing IRF. I.e., in
regions where the peak heights in the ringing IRF decay linearly with time (peaks at later
time points), the constant magnitude ratio between the two peaks in the filter enables
similar-valued integrals between the smaller-magnitude peak in the filter function
(overlapped with a larger peak in the IRF) and the oppositely-signed larger-magnitude
peak in the filter function (overlapped with a small peak in the IRF). The filter thus
removes smaller magnitude peaks in the ringing IRF. It is proposed that the assumption
of linearity in the IRF peak height decay is least valid for the first ~2 peaks in the IRF.
This leads to a non-zero dot product when the filter function reaches this part of the IRF
(sliding dot product), thereby yielding a pseudo-impulse in the filtered time domain
response.
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Comparison of LDA-based digital filtering with other techniques to increase the
LDR of photon counting measurements was assessed through simulations of the ringing
IRF across several orders of magnitude of photon count rates. The results are summarized
in Figure 7.7. Photon counting after application of only a HP filter (removal of rolling
background but retention of ringing in the IRF) yields inaccurately high count rates due
to multiple peaks registering above the threshold for a single photon event. Pulse pile up
also leads to saturation of the counting regime at ~5 Mcps. Imposing a dead time
following a counting event (paralysis) recovers the true photon count at low count rates,
as the dead time is selected considering knowledge of the IRF. Unfortunately, the LDR of
paralysis is severely limited, as only count rates above ~100 kcps show bias due to
photons arriving within the detector dead time. In contrast, the LDA + HP digital filter
recovers accurate count rates up to ~50 Mcps, demonstrating an improvement in the LDR
of the photon counting measurement.
Digital filtering lowered the overall SNR of the measurement (as anticipated), due
to diminished high frequency content (decreased peak integrated area) in the filtered data.
This is evidenced by the model data shown in Figure 7.3, as the calculated SNR (defined
here as the peak voltage divided by the standard deviation of the background) for peaks
there-in dropped from 65 in the unfiltered data to 22 following digital filtering.
Fortunately, in the assumption that the SNR is still sufficiently high to enable photoncounting, such a loss in the overall SNR is not anticipated to be problematic, as
information such as peak heights is not retained in traditional photon counting methods.
Indeed, the ability to recover temporal impulses and the associated increase in the LDR
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and accuracy of photon arrival times of the measurement (Figures 7.3 and 7.5) offsets the
SNR decrease.
The recovery of a deconvolved time-trace by LDA-based digital was compared to
two alternative strategies: nonlinear curve fitting and Richardson-Lucy digital
deconvolution. Nonlinear peak-fitting of the data using standard approaches from
spectroscopy and chromatography can suppress the background noise and provide the
origins of overlapping peaks more accurately than digital deconvolution in most
instances. However, peak fitting is an iterative procedure requiring initial guess values,
complicating application for streaming data analysis. Furthermore, peak-fitting requires
the a priori assumption of a known functional form for the peaks. Preliminary estimates
based on optimized algorithms in MatLab suggest fitting times of 1.7 s per photon event
for the fitting of a single ringing waveform, corresponding to approximately 5 days to
process each frame in a video rate acquisition with a mean of 0.05 photons per pulse.
Alternative digital deconvolution approaches were also assessed, based on the iterative
Richardson-Lucy deconvolution algorithm. As with many deconvolution approaches, the
Richardson-Lucy algorithm requires a priori determination of the noise free instrument
response function. In general, deconvolution with the Richardson-Lucy approach
recovered impulse responses with comparable or higher signal to noise than the LDAbased approach, but at the expense of considerable additional computational time.
Preliminary assessments using Matlab built-in algorithms required between 10 s to 100
s per data point on average to perform the deconvolution, corresponding to a little more
than 8 seconds to roughly a minute per frame. While reasonable for a single frame of
acquired data, the need for at least 8 seconds to perform the data analysis represents a
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significant gap to bridge relative to the 15 fps data acquisition rate. From this analysis,
the long times required for nonlinear curve fitting and for iterative deconvolution using
the Richardson-Lucy algorithm are incompatible with real-time data analysis at the
experimental 80 MHz repetition rate for each channel.
Clearly, the improvements afforded by deconvolution must also be weighed
against the computational costs associated with the data processing based on the
particular application. For real-time data processing at the high data throughput rates used
in this study, digital filtering arguably represents the fastest approach for performing
digital deconvolution in terms of computational cost. Direct digital filtering for
deconvolution can be performed in as little as 2 clock cycles of a FPGA when
parallelized.16 FPGA clock speeds in the hundreds of MHz are currently available,
allowing direct real-time analysis at data throughput rates exceeding the 80 MHz
acquisition rates of the present study. However, there is still an initial expense associated
with the design of the appropriate digital filter. The LDA approach described herein
requires significant training to reduce the noise inherent in the filter function. Provided
the impulse response function does not change substantially over the time-course of a
measurement as in the photon counting applications described herein, this initial
investment may be easily justified by enabling subsequent high speed data analysis
through simple digital filtering.
It is significant that one LDA algorithm performed reasonably well for multiple
very different impulse response functions. No explicit models were required for treating
the measurement noise or the variance in signal intensities. All of these effects were
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implicitly incorporated into the algorithm through the training set used to produce the
LDA filters.

7.5 Conclusions
A novel digital filter derived from two class LDA has been shown to increase the
LDA of photon counting measurements by over an order of magnitude. The filter is
created through defining temporally coincident (class 1) and non-coincident (class 2)
voltage transients, with the Fisher discriminant serving directly as the filter function.
Following training, the digital filter can be used to recover a temporal impulse in raw data
from a variety of IRFs. The digital filter was validated through both simulated photon
counting measurements as well as experimental TPE-UVF images. With additional
engineering efforts for implementation via FPGAs, the algorithms proposed here-in have
the potential to enable rapid, high-dynamic range data acquisition in a variety of
counting-based measurements.
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Figure 7.1 Illustration of the process of digital filtering. The dot product between the
signal (blue) and the digital filter (red) yields a scalar value coincident with the origin of
the filter. By sliding this dot product along the length of the data, the filtered data (green)
is produced.
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Figure 7.2 Generation of the digital filter from 2 class LDA. Temporally coincident (left
column) and non-coincident (right column) voltage transients make up the two classes.
LDA allows recovery of the Fisher discriminant (below left) which is used directly as the
filter function. Below right: projection of each training set onto filter space.
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Figure 7.3 Model data at a variety of photon flux rates showing the recovery of temporal
impulses (blue) from the raw data (red). Removal of voltage transient overlap by LDA
digital filtering enabled accurate recovery of every ground truth photon event (pink bars).
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Figure 7.4 Receiver operating characteristic curve for LDA filtered data. Given
appropriate threshold settings, the error rate is relatively low even at very high photon
flux rates, expressed as the mean of the underlying Poisson distribution (=0.4).
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Figure 7.5 Application of the LDA digital filter to correct for a ringing waveform. A)
ringing waveform created through impedance mismatch in the ADC. B) LDA-derived
digital filter. C) Raw data (red), LDA-digital filtered data (green) and LDA digital
filtered data after high-pass filtering to remove rolling background features (blue).
Temporal impulses are recovered (blue trace) despite substantial ringing in the raw data
(red).
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Figure 7.6 Experimental TPE-UVF images of L-Tryptophan. A) Ground truth image
from an impedance-matched data channel. Inset: raw time domain data. B) Raw image
from impedance mismatched channel. Inset: raw time domain data showing ringing
artifacts. C) Image from B) following high-pass filtering to remove baseline drift. Inset:
raw time domain data showing reduction in baseline drift, but retaining significant
ringing artifacts. D) Image from C) following LDA digital filtering. Inset: raw time
domain data showing removal of the ringing artifacts.
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Figure 7.7 Summary to simulations to asses the LDR of LDA digital filtering. A common
approach for pulse pile up correction (paralysis) is shown in green, which recovers the
true number of photons only at very low count rates. High-pass filtering only is shown in
blue. Due to ringing present in the IRF, high-pass filtering alone significantly overestimates the count rate. LDA plus high-pass digital filtering is shown in red, exhibiting a
LDR approximately an order of magnitude larger than HP filtering alone.
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ABSTRACT: Second harmonic generation (SHG) microscopy
was used to rapidly identify regions of interest for localized
confocal Raman spectroscopy measurements in order to
quantify crystallinity within lyophilized Abraxane powder
(protein bound paclitaxel for injectable suspension). Water
insoluble noncentrosymmetric crystalline particles ranging from
∼1 to 120 μm were identiﬁed by SHG, with wide variability
in crystal size and frequency observed between several batches
of Abraxane. By targeting the Raman analysis to these localized
regions identiﬁed by SHG, the required measurement time
was decreased over 2 orders of magnitude, from 8 h to 2 s.
Experimental Raman spectra of SHG active domains in
Abraxane were in good agreement with experimental spectra
of pure crystalline paclitaxel. These collective results are consistent with up to 30% of the active ingredient being present as poorly
soluble crystalline particulates in some batches of Abraxane.
KEYWORDS: second harmonic generation, amorphous formulations, nanosuspensions, Raman spectroscopy, microscopy, paclitaxel,
Abraxane, lyophilization
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INTRODUCTION

strategies that minimize the use of additives with undesirable
side-eﬀects are of great interest. Recently, nanosuspensions17−20
such as nanoparticle albumin-bound (NAB) paclitaxel16 have
been found to oﬀer a potentially promising solution to this
problem. NAB paclitaxel (PTX) is manufactured through
coprecipitation with human serum albumin (HSA), leading to
an amorphous formulation.16 Upon reconstitution, this formulation is a nanosuspension containing particles ca. 130 nm in
diameter.
Quantiﬁcation and detection of crystallinity at low levels within
such an amorphous formulation is often a deﬁning measurement
for predicting the long-term success of the product. For IV
formulations in particular, crystal formation is detrimental because
it not only reduces the solubility advantage of the amorphous
formulation, but the presence of large, insoluble particulates is
problematic and hence subject to stringent regulations.13,21,22
Unfortunately, for potent APIs at low loadings, accurate
determination of crystallinity poses a signiﬁcant measurement
challenge. As the drug loading approaches the detection limits
of conventional benchtop methods, even major diﬀerences in

Modern drug discovery frequently identiﬁes active pharmaceutical ingredients (APIs) that are highly eﬀective against the disease
target but that are hard to deliver to the biomedical target.
Increasingly, new compounds exhibit low aqueous solubility,
whereby it is estimated that some 40% of new chemical entities
are discarded for this reason.1 Many solubilization strategies are
designed to address this issue. One of the most common
methods toward this end is the preparation of amorphous
formulations in which the API is molecularly dispersed in a
noncrystalline highly soluble matrix to increase the dissolution
rate and transient concentration.2−10 Unfortunately, most such
formulations are inherently metastable and run the risk of
spontaneously transitioning to their more thermodynamically
stable crystalline form. If such phase changes occur either in the
formulation preparation or during storage, signiﬁcant reductions
in drug bioavailability may arise.
For intravenous (IV) formulations, incomplete solubilization
of the API introduces additional embolism risks associated
with blood vessel occlusion by circulation of poorly soluble API
particulates. Therefore, various diﬀerent strategies to solubilize
APIs are employed, including pH adjustment and/or the use
of cosolvents, surfactants, or emulsiﬁers.11−13 Unfortunately,
additives used to solubilize drugs for IV formulations can exhibit
toxicity,14,15 in some cases fatal.16 Therefore, solubilization
© 2015 American Chemical Society
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solubility arising from an amorphous nanosuspension, it is
thought that Abraxane achieves higher treatment speciﬁcity
as a result of its HSA matrix, utilizing the known high protein
uptake rate of tumors.20,50−52

relative drug crystallinity become diﬃcult to distinguish with
statistical conﬁdence. Commonly used methods for crystal
detection and characterization in the drug formulation pipeline
include X-ray powder diﬀraction (PXRD), diﬀerential scanning
calorimetry (DSC),23 Raman spectroscopy,24,25 scanning electron
microscopy (SEM),26,27 hot stage microscopy,28 and solid-state
nuclear magnetic resonance spectroscopy (SSNMR).29 However,
most of these techniques do not typically exhibit detection limits
for crystallinity signiﬁcantly lower than ∼1%, in most cases
because of background noise from the much larger noncrystalline
fraction. Additionally, the composition of NAB PTX makes
assessment by several of these methods problematic. The use
of HSA as the formulation matrix would make detection of
crystallinity by DSC diﬃcult due to the low denaturation
temperature of the protein matrix. While SEM has been used in
accelerated stability studies of amorphous formulations,26,27
several limitations complicate its application toward the analysis
of bulk NAB PTX. As a surface characterization tool, the use
of SEM for monitoring crystallization is generally limited to
crystallization events taking place on the formulation’s exterior or
within a thin ﬁlm, making characterization of a powdered, bulk
material more diﬃcult.
With detection limits for crystallinity approximately an orderof-magnitude lower than mentioned above, SSNMR has been
used to quantify and characterize crystalline content within
a variety of powdered samples.30−33 SSNMR characterization
of NAB PTX was previously performed in the course of patent
litigation (Elan Pharma International Ltd. v. Abraxis BioScience
Inc., United States District Court for the District of Delaware)
in 2008.34,35
Nonlinear optical (NLO) microscopy, in particular second
harmonic generation (SHG), has recently emerged as a complementary technique for the rapid detection and quantiﬁcation
of trace crystallinity within pharmaceutical materials.36−41
Coherent SHG selectively arises exclusively from the bulk
crystalline fraction and only within crystals of appropriate
symmetry. The chirality inherent in most new pharmaceutical
APIs largely guarantees that the crystals produced will be
bulk-allowed for SHG. This selectivity for crystalline API has
allowed measurements with detection limits on the order of
parts per billion to as low as parts per trillion ranges under
favorable conditions.42
Despite the low detection limits of SHG microscopy, the
SHG intensity itself provides little signiﬁcant chemical information about the composition of the SHG-active source. In the
present study, eﬀorts were undertaken to lower the detection
limits of Raman spectroscopy through targeted analysis
guided by SHG imaging. In brief, targeting Raman analysis to
regions of interest preidentiﬁed by SHG minimizes the volume
of additional material that must be probed in conventional
chemical imaging modalities.
In the present study, assessment of this SHG-guided analysis
approach was performed for the amorphous IV formulation
Abraxane (nanoparticle albumin bound paclitaxel for injectable
suspension). Abraxane was the ﬁrst nanosuspension approved for
clinical use13,16 and is indicated to contain 10% (w/w) PTX
bound to nanoparticles of HSA. Abraxane has been shown
to have increased eﬃcacy compared to other PTX formulations (e.g., Taxol), particularly in the treatment of breast
cancer,16,43,44 nonsmall cell lung cancer,45−48 and pancreatic
carcinoma. 49 PTX is generally regarded as exhibiting
substantial solubility limitations, with crystalline PTX exhibiting poor bioavailability.13 In addition to the increased apparent
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METHODS

Abraxane samples were analyzed in their native (solid) form
as obtained from the manufacturer. Four diﬀerent batches
were imaged (lot numbers: 6106359, 6106934, 6107014, and
6107321, batches 1−4 respectively). SHG images were
acquired with a commercial SONICC (second-order nonlinear
optical imaging of chiral crystals) microscope (Formulatrix, Inc.).
The system contains a Fianium FemtoPower laser (1060 nm,
1.3 W power output), with a 51 MHz repetition rate and a
166 fs pulse width. The instrument uses resonant mirror/
galvanometer beam scanning (8 kHz fast axis) to generate
images. Unless otherwise stated, all SONICC images were
acquired with 250 mW infrared (IR) power at the sample, with
a 2 s image acquisition time. SHG light was collected in the
transmission direction, requiring the preparation of thin samples
to minimize scattering losses. In brief, samples were prepared by
placing a small aliquot of powder between two glass coverslips,
within a thin (∼100 μm) spacer to ensure uniform sample
thickness.53 Twelve ﬁelds of view (FOV) were obtained for each
sample and used to generate particle histograms. The fraction
imaged by SHG represents approximately 1% of the 1 g bulk
sample, and a total volume probed of 2.2 mm3 (12 ﬁelds of view
with dimensions of 1925 μm × 1925 μm × 50 μm). For analysis
of relative PTX crystallinity in batch 1, physical mixtures of
crystalline PTX in HSA (Attix Pharmaceuticals) (0.1−5% drug
loading) were prepared as standards for a calibration curve.
Given the 10% (w/w) loading of PTX in Abraxane, these
standards correspond to 1−50% relative crystallinity of the PTX.
While it is possible the PTX used to create the calibration curve

Figure 1. SHG images of batches 1−4 (A−D, respectively) of
Abraxane. Insets show line scans across an individual crystalline
domain for each image, in units of megacounts per second (Mcps).
All images are shown on the same brightness scale. Large variations in
crystallinity are readily apparent.
2379
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standards diﬀers in crystal form from the PTX present within
Abraxane, the two most common hydrate crystal forms listed in
the Cambridge Structural Database (i.e., neglecting nonaqueous
solvates) are of the same crystalline space group with nearly
identical lattice constants. Among crystals of identical building
blocks, the average observable SHG intensity is dictated
primarily by the crystalline space group. In the case of these
two hydrates (entry IDs RIGLAW and RIGKUP), the average
observable SHG intensities are assumed to be identical.
Raman images were acquired on an alpha300 AR commercial
confocal reﬂectance Raman microscope (WITec) with a 633 nm
HeNe source and 35 mW output (Melles Griot). A 10×
objective (0.25 NA) was used, giving a beam waist of 0.8 μm
and a depth of ﬁeld of 20 μm. WITec Control 1.60 was used
for data collection. Speciﬁc ﬁelds of view (300 μm × 300 μm)

containing a region of interest within the bulk powdered sample
were ﬁrst located via SHG and then marked for subsequent
confocal Raman analysis. With the crystalline domain located
at the center of the marked 300 μm × 300 μm FOV, repositioning on the Raman microscope via bright ﬁeld imaging was
quite reproducible, allowing the crystallite to be located via
spectral analysis with minimal searching. Each spectrum was
acquired with 4 min of integration time, followed by high-pass
digital ﬁltering to remove ﬂuorescence background. Bench top
powder X-ray diﬀraction (PXRD) was acquired on a Rigaku
SmartLab diﬀractometer (0.1544 nm wavelength) scanned at
one degree/min.

■

RESULTS AND DISCUSSION

Figure 1 shows SHG images of four diﬀerent batches (varying
lot numbers) of Abraxane. A representative SHG image of pure
HSA (negative control) is shown in the Supporting Information,
Figure SI-1. Samples were imaged in powdered form, as received
from the manufacturer. All images are shown on the same
brightness scale. Insets show line scans across a single particle
in each batch in units of megacounts per second (Mcps).
High variation in crystallinity and particle number/size between
batches is readily observed.
A sample from batch 1 was imaged with SHG both before
and after dissolution in ultrapure water, the results of which are
shown in Figure 2. This experiment was performed primarily to
exclude possible SHG interferences from the relatively small
fraction of buﬀer salts known to form noncentrosymmetric and
therefore SHG-active crystals.54 It would not be unreasonable
for salts to exist within the formulation given the use of
HSA as the matrix. However, all such compounds are highly
water-soluble and would not be expected to remain following
addition of water to the sample. Furthermore, solubilization
in water mirrors the recommended procedure in preparation
for parenteral introduction. Figure 2 summarizes these results,
showing a bright ﬁeld image of Abraxane in the solid state (a),
bright ﬁeld and cross-polarized images of individual crystallites
within Abraxane suspension (b), and SHG images of solidstate and suspended Abraxane (c and d, respectively). SHG
active areas remained even after dissolution in ultrapure water
combined with vigorous mixing, suggesting that the SHG-active
material exhibited poor aqueous solubility and was unlikely to
be an SHG-active buﬀer salt. Additionally, these crystallites are
likely to remain unsolubilized within Abraxane suspension.

Figure 2. Bright ﬁeld (A,Bi and Biii), cross-polarized (Bii, Biv), and
SHG (C−D) images of Abraxane before and after dissolution in
ultrapure water followed by rigorous mixing. Results show that SHG
active regions exhibit poor aqueous solubility. In addition to this direct
assessment of formulation solubility, these results indicate that the
SHG active regions are unlikely to arise from water-soluble noncentrosymmetric buﬀer salts.

Figure 3. SHG image (A) and corresponding confocal Raman spectra after digital high-pass ﬁltering (B). The blue and red traces shown in B were
taken at the indicated locations of regions I and II, respectively. For comparison, the black and green traces show the experimental spectra of pure
PTX and pure HSA (blank), respectively. Experimental spectra for pure PTX and for SHG active domains in Abraxane agree well. High SNR present
at 1007.1 and 1604.3 cm−1 within these two spectra is consistent with higher local PTX concentration within an SHG active domain of Abraxane.
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Additional confocal Raman measurements were performed
selectively on the regions of interest identiﬁed as the SHGactive domains in the native Abraxane dosage form, the results
of which are summarized in Figure 3. With initial screening
by SHG, a crystalline domain of interest (∼20 μm diameter)
within a 300 μm × 300 μm FOV was marked for subsequent
analysis, shown in Figure 3a. Figure 3b summarizes the experimental Raman spectra acquired within the region of interest
and elsewhere in the FOV. For comparison, the experimental
Raman spectra of pure PTX and pure HSA are also shown.
The Raman spectrum acquired from the SHG-active region of
interest agrees remarkably well with the measured spectrum
of pure crystalline PTX. Furthermore, the peak heights were
notably greater in the SHG-active region, consistent with a
higher local concentration of PTX relative to other locations
within the formulation. In addition, the two peaks at 1007.1 and
1604.3 cm−1 are most pronounced in the crystalline PTX spectrum,
as well as in that of the SHG-active region, but are only marginally
detectable in other locations within the formulation.
If the SHG-active and poorly soluble fraction of material in
Abraxane is attributed to PTX, SHG microscopy can be used
to estimate the relative crystallinity of the active ingredient
within the formulation. A calibration curve of SHG signal was
constructed from physical mixtures of crystalline PTX in HSA at
various loadings, accounting for the 10% (w/w) loading of PTX
in Abraxane. The PTX within batch 1 was found to be 30 ± 13%
(95% CI) crystalline, corresponding to 3.0% overall crystallinity
in the measured lot of Abraxane. The relatively large uncertainty
in the crystallinity arose primarily from the limited volumes
of materials probed, resulting in statistical ﬂuctuations in the
crystalline fraction per probed volume. Such a large fraction of
PTX present in a crystalline state may potentially impact the
eﬀective dose of the formulation. Analysis by PXRD failed to
show any peaks, consistent with these relatively low levels of
crystallinity. A representative PXRD pattern is shown in the
Supporting Information, Figure SI-2.
The spatial information aﬀorded by SHG also allows assessment of the size distribution of poorly soluble particulates
in situ within the ﬁnal dosage forms. Histograms of SHG-active
particle sizes are shown in Figure 4 for batches 1, 3, and 4 (a−c,
respectively) as batch 2 did not contain enough particles to
produce a meaningful histogram. From these results, diﬀerent
lots exhibited diverse distributions, with particle size ranging
from <10 μm to over 120 μm. As the mass fraction probed by
SHG represents approximately 1% of the container contents,
the observation of 37 particles greater than 26 μm within the
imaged fraction of batch 1 suggests approximately 3700 (±600)
particles >26 μm present within the ﬁnal dosage form, with
the determined standard deviation based on Poisson statistics.
This degree of direct access to the size distribution of insoluble
crystalline particles would be challenging to obtain in situ within
the solid-state ﬁnal dosage form using alternative standard
methods given the optical opacity of the Abraxane formulation
but is reasonably straightforward to access by SHG imaging.
This initial screening by SHG greatly reduced the time required
to perform the Raman measurements. For a typical line-scan
commercial Raman imaging approach, the laser power required
to obtain the SNR present in Figure 3 for a 256 pixel laser
line would be approximately 9 W. In the assumption that this
power does not represent a laser-limited measurement and
by decreasing the per pixel integration time to 30 s (acceptable
minimum SNR for identiﬁcation), it would take approximately
8 h of continuous data acquisition to map out a given ﬁeld of

Figure 4. Histograms of crystal size for batches 1, 3, and 4 of Abraxane
(A−C, respectively) with occurrence reported as particle number
density. Not enough crystallites were present in batch 2 to produce a
meaningful histogram. Insets show higher size ranges. Crystals up to
120 μm are present in Abraxane, with substantial variability in particle
density and size between the measured batches.

view with equivalent (512 × 512) resolution, compared to
2 s/FOV used for the SHG images. This represents a reduction
in the measurement time of over 2 orders of magnitude. It is
further of note that the SNR present in these SHG images
(∼500 for the line scan in Figure 1a) could be equivalently
reduced, decreasing the required SHG measurement time well
into the video-rate regime.

■

CONCLUSIONS
Using SHG microscopy to identify regions of interest within
an amorphous pharmaceutical formulation was found to enable
targeted analysis by Raman spectroscopy. By guiding Raman
measurements to only these regions of interest, the measurement time was reduced by over 2 orders of magnitude relative
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to established benchtop instruments. Characterization of the
amorphous nanosuspension Abraxane illustrated this process
for a drug formulation currently in clinical use. Substantial
variability in relative crystallinity was observed within the product as-received, with water-insoluble particles up to 120 μm
observed in the formulation. SHG-guided analysis by Raman
spectroscopy was consistent with crystalline paclitaxel comprising the poorly soluble particles. These combined results
illustrate the potential beneﬁts provided by the marriage of
the rapid and highly selective technique of SHG with
information-rich spectroscopic methods such as Raman.
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ABSTRACT: The use of nonlinear optical Stokes ellipsometric (NOSE) microscopy for rapid discrimination of two
polymorphic forms of the small molecule D-mannitol is
presented. Fast (8 MHz) polarization modulated beamscanning microscopy and a recently developed iterative,
nonlinear least-squares ﬁtting algorithm were combined to
allow discrimination of orthorhombic and monoclinic crystal
structures of D-mannitol with data acquisition times of <7 s per
ﬁeld of view with a signal-to-noise ratio (SNR) of ∼300.
Discrimination between polymorphic forms within the 99.99%
conﬁdence interval was achieved by standard statistical tests of
the recovered probability density functions for the measured observables following two class linear discriminant analysis. These
measurements target bottlenecks in small-volume, high-throughput solid form screening experiments for polymorph discovery in
the development of emerging active pharmaceutical ingredients.

P

mass of puriﬁed materials are reduced. Techniques such as
Raman spectroscopy,18−21 Fourier transform infrared spectroscopy (FT-IR),22 powder X-ray diﬀraction (PXRD),16,18,20,23
diﬀerential scanning calorimetry (DSC),18 and optical microscopy8,16,20 are currently used to assess the polymorphic form of
hits. Unfortunately, the time required for characterization by
these methods creates a bottleneck in the screening process
that is ultimately limiting the number of screenable conditions.
While Raman spectroscopy generally provides shorter characterization times (a few sec/measurement)20 relative to other
techniques such as PXRD (current state of the art requires ∼60
s/measurement using benchtop systems),16 the overall time
required to analyze the results of several thousand crystallization experiments routinely limits the number of trials that
can be prepared and run. This disparity is often compounded
by the need for characterization by more than one analytical
method, such that completion of a HT study for a new drug
candidate can take several weeks to complete.8 The analysis of
already known crystal forms may occupy a large portion of this
characterization time. Furthermore, the existing measurement
time bottleneck is only likely to pose even greater challenges for
throughput as the decreased crystal mass in each well in highthroughput screens lowers the overall SNR in the measurements. Additionally, preferred orientation eﬀects become
increasingly important in small samples as the ﬁnite set of
crystals results in a stochastic set of discrete crystal
orientations.24,25 Preferred orientation can signiﬁcantly com-

olymorphism, or the presence of multiple crystal forms for
a single molecular building block, is an important
characteristic in the development of therapeutic small
molecules.1−5 As diﬀerent polymorphs and crystal forms can
exhibit widely varying physiochemical properties, including
overall formulation stability and drug solubility, precise control
over crystal form can be critical for reliable drug performance
and product quality control.1,2,6−8 Additionally, a thorough
characterization of generally accessible polymorph and cocrystal
forms is typically performed prior to establishing intellectual
property rights on pharmaceutical formulations.9,10 The
importance of control over drug polymorphic form is perhaps
best illustrated by the 1998 recall of Norvir (oral capsule
formulation of the HIV protease inhibitor ritonavir) upon
discovery of a more thermodynamically stable polymorphic
form with decreased oral bioavailability.11 As a result of these
motivations, drug development laboratories spend considerable
resources on discovering and characterizing the polymorphic
forms of an emerging active pharmaceutical ingredient
(API).12−14
Trends in the pharmaceutical industry are shifting crystal
form analysis to earlier stages in the pipelines, targeting analysis
of a greater diversity of samples to test with ever smaller
quantities of puriﬁed product available for testing. Highthroughput (HT) crystallization procedures intended to
empirically map polymorphic space for a new drug candidate
are playing an increasingly important role in new form
discovery.8,15−17 While the parallel approach of HT crystallization technology oﬀers an overall time savings over
traditional serial “batch” approaches, the characterization of
all crystal forms within multiwell plate crystallizations
represents a nontrivial measurement task as the available
© XXXX American Chemical Society
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plicate automated analysis of the observed spectra; rotation is a
nonlinear operation, such that the measured Raman spectra and
XRD patterns produced from nonrepresentative sampling
generally cannot be expressed as simple linear combinations
of pure components. As a result, linear decomposition methods
of the spectra such as principal component analysis and linear
discriminant analysis are often intractable. A need has thus
emerged for additional complementary characterization approaches that can decrease characterization times for trace
quantities of material in HT new crystal form discovery.
Second harmonic generation (SHG) has been suggested as
an alternative method for crystal polymorph determination. In
studies by Rades et al., diﬀerences in the angle-dependent SHG
scattering were linked to changes in crystal form.26 However,
conventional powder analysis by SHG is limited primarily to
diﬀerences in the overall intensity produced by a powder,27,28
which provides fairly small discriminatory capability, requires
suﬃciently large samples to provide representative sampling as
in XRD and Raman, and is highly dependent on crystal size
eﬀects.29,30 Nonlinear optical Stokes ellipsometry (NOSE),
combining rapid (8 MHz) polarization modulation of the
incident beam and polarized detection of the second harmonic,
has recently been shown as a measurement technique sensitive
to small molecule crystal orientation,31−33 increasing the
information content of previous SHG microscopy studies.34
Although not explored in these previous studies, NOSE has the
potential to alleviate measurement bottlenecks found in HT
crystallization studies through the Boolean discrimination and
subsequent removal of already-discovered crystal forms from
more time-consuming analysis pipelines. Because NOSE is
based on polarization-dependent measurements, it has selfreferencing measurement advantages over SHG measurements
based on intensity alone. Additionally, recovery of individual
crystal orientations by NOSE microscopy allows tensor analysis
in the local-frame of the crystal, such that crystal form
determination can potentially be achieved even in samples
containing only a handful of microcrystals. Polymorphic
analysis by NOSE has the additional potential advantages of
being fast (approaching video-rate) and nondestructive.
Combining NOSE with birefringence and traditional optical
microscopy all acquired simultaneously on one platform also
opens up the possibility for the combination of multimodal
analyses.31
Here, we assess the potential merits of NOSE for rapid
crystal form discrimination using two polymorphic forms of the
small molecule D-mannitol. D-mannitol was selected as a model
system for several reasons. First, several polymorphic forms are
readily accessible via simple room-temperature recrystallizations.35 Additionally, D-mannitol is an exceedingly common
small-molecule excipient used in pharmaceutical formulations.
Disentanglement of crystal structure and orientation allows the
recovery of local (crystal) frame nonlinear optical tensor
elements describing the polarization-dependent SHG eﬃciency
for a given crystal. These unique tensor elements are one of
several quantities which serve as the experimental observable
for discrimination on a per-crystal basis. Polymorph discrimination based on NOSE is shown for orthorhombic (P212121)
and monoclinic (P21) structures of D-mannitol. The potential
for discrimination was assessed from measurements of only ∼1
μg of material, consistent with sample masses found in small
volume HT crystallization studies.

Article

MATERIALS AND METHODS

Experimental Section. D-mannitol was purchased from
Sigma-Aldrich. Orthorhombic and monoclinic forms of Dmannitol were crystallized from diﬀerent solvents according to
previously published protocols.36,37 The orthorhombic form
was recrystallized from 70/30 ethanol/water, and the
monoclinic form was obtained via an antisolvent crystallization
from 50/50 water/acetone. Powder X-ray diﬀraction (PXRD)
patterns were obtained on a Rigaku SmartLab X-ray
diﬀractometer, using a wavelength of 1.554 Å and a scan
speed of 0.6° 2θ/min. Acquired PXRD patterns were compared
to those predicted by Mercury (Cambridge Structural Database,
CSD). 41 Entry IDs of CSD entries were DMANTL8
(orthorhombic) and DMANTL14 (monoclinic).
NOSE images were acquired on a custom microscope
capable of 8 MHz polarization modulation described in detail in
several previous publications.31,33 In brief, an 800 nm, 80 MHz,
100 fs Ti:sapphire laser (SpectraPhysics) at an average incident
power of 200 mW was used as the light source and focused
onto the sample using a 10×, 0.3 NA objective (Nikon). The
laser served as the master clock for the beam-scanning and data
acquisition electronics. The microscope utilized a resonant
mirror (∼8 kHz, EOPC)/ galvanometer mirror (CambridgeTech) for beam scanning and PCI express digital oscilloscope
cards (AlazarTech) as the analog to digital converter (ADC).
SHG was separated from the fundamental via a series of
dichroic/band-pass optical ﬁlters, and photomultiplier tubes
(PMT) (Hamamatsu) were used as detectors. An electro-optic
modulator (EOM) was used for polarization modulation at 8
MHz (laser served as master clock), and was oriented at +45°
from its fast axis. Glan-Taylor polarizers (GTs) were placed
before the two PMTs (transmission direction), with a quarter
wave plate (QWP) oriented at +22.5° placed after the sample,
prior to the polarizer. A GT was also placed before a
photodiode (transmission direction) to allow polarized
detection of the laser fundamental.
Computational. Following image acquisition, OrientationJ38,39 (NIH ImageJ)40 and custom Matlab software were
used for analysis. ImageJ was used to threshold the SHG
images, allowing particle (crystal) analysis. The SHG intensity
for each input polarization was averaged across each individual
crystal. The 10 polarization-dependent responses are then
contracted down to a set of ﬁve Fourier coeﬃcients via linear
least-squares ﬁtting (Matlab) as described previously.31 These
Fourier coeﬃcients are a function of both sample orientation
(described by Euler angles θ, ψ, and ϕ) and intrinsic
polarization-dependent nonlinear optical susceptibility. A
custom iterative, nonlinear least-squares ﬁtting algorithm was
developed for the analysis of NOSE images. This algorithm has
been described in detail in related publications,32,33 and
recovers two unknown orientation angles (θ, ψ), the percrystal SHG intensity, and the values of the local-frame
nonlinear optical susceptibility tensor elements. For each crystal
in the image (particles identiﬁed via ImageJ), the in-plane
azimuthal rotation angle (ϕ) was measured with the
OrientationJ plug-in (NIH ImageJ). Images showing the
recovered values of ϕ for a sample ﬁeld of view for both
polymorphs are shown in the Supporting Information, Figure
SI-2.
Following conversion of the Fourier coeﬃcients to an
alternative set of polynomial coeﬃcients,31 the coeﬃcients and
in-plane orientation angles for each crystal were used as inputs
B
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Figure 1. Experimental (solid trace) and predicted (dotted trace) PXRD patterns for orthorhombic (blue, bottom) and monoclinic (red, top) crystal
structures of D-mannitol. Patterns are artiﬁcially oﬀset vertically for clarity. Predicted patterns were obtained from the Cambridge Structural Database
(CSD), entry IDs DMANTL8 and DMANTL14, respectively. General agreement between the experimental and theoretical 2θ values and relative
intensities was observed.

into the iterative ﬁtting algorithm. In the ﬁrst step, a userdeﬁned set of local-frame nonlinear optical susceptibility tensor
elements and the in-plane orientation angle (recovered from
OrientationJ) were assumed, and a nonlinear least-squares ﬁt of
the polynomial coeﬃcients to recover the remaining two
orientation angles and the per-crystal SHG intensity was
performed. Following completion of the ﬁt, the ﬁtted values for
θ, ψ, and the per-crystal SHG intensity were assumed explicitly,
and an additional nonlinear least-squares ﬁt to recover localframe tensor element values (constrained ﬁt) was then
performed. This entire process was iterated until the system
converged. As described in the related publications,32,33 the
algorithm has been validated on both theoretical data of
multiple symmetries and thinly sectioned porcine/mouse
collagenous tissue samples. Due to sensitivity of the recovered
orientation angles on initial parameter guess values (i.e.,
equivalent solutions are found), the iterative algorithm was
subjected to 100 independent runs with randomized guess
values for θ and ψ. The mode of the recovered values for the
local-frame tensor elements and orientation angles for each
crystal was used for subsequent analyses.
The symmetry properties of the D-mannitol structures
studied herein yield 3 and 13 unique nonzero tensor elements
for the orthorhombic (P212121) and monoclinic (P21)
structures, respectively. Together with two orientation angles,
this yields 5 and 15 recovered variables, respectively, for the
measurement. As the number of recovered parameters for the
P21 structure exceeds the number of observables, direct
recovery of all unique nonzero tensor elements for the
monoclinic form is not anticipated to be accurate (high
covariance) and was thus not attempted. However, the goal of

this study is simply Boolean discrimination of orthorhombic
structures for the purpose of identifying common crystal forms.
Accordingly, NOSE measurements of both the monoclinic and
orthorhombic crystal structures were ﬁt to the equations
describing the orthorhombic response to recover three unique
local-frame tensor elements (along with per-crystal SHG
intensities and two orientation angles) for each crystal
structure. Following 2-class linear discriminant analysis
(LDA) for optimal dimension reduction, statistical tests (F
test and t test) were then used to provide a quantitative means
of making the Boolean structure discrimination through
comparison of the probability density functions (pdfs) giving
rise to the responses for the “known” form (orthorhombic) and
the “unknown” form (monoclinic).

■

RESULTS AND DISCUSSION
was crystallized into two polymorphic forms via
recrystallization from common solvents. These two forms adopt
orthorhombic (P212121) and monoclinic (P21) symmetries.
Conﬁrmation of the two crystal structures was performed via
PXRD. Figure 1 contains the observed diﬀraction data together
with the predicted patterns from the Cambridge Structural
Database (CSD)41 for both the orthorhombic (CSD ID
DMANTL8) and monoclinic (CSD ID DMANTL14) crystal
forms, based on the reported lattice constants and nuclear
electron densities. Although there are some disparities in the
relative peak heights, excellent agreement between most 2θ
diﬀraction angles is generally observed.
NOSE colormaps of orthorhombic (left column) and
monoclinic (right column) forms of D-mannitol are shown in
Figure 2 for both the horizontally polarized PMT (H PMT)
D-mannitol

C
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In2ω

= an + bn cos(2Δ) + cn cos(Δ) + dn sin(Δ)

+ en sin(2Δ)

(1)

The polarization state of the incident light emerging from the
EOM is dependent on the phase shift Δ in eq 1, with the values
of a−e Fourier coeﬃcients shown as merged red, green, blue,
cyan, and magenta (RGBCM) images in Figure 2. The relative
magnitude of each coeﬃcient (a−e) provides the color
weighting (RGBCM, respectively) within each pixel of the
image. These images thus contain all polarization-dependent
NLO information recovered from the measurement. Example
single color Fourier coeﬃcient images are shown in the
Supporting Information (Figure SI-1). As described previously,31 further analyses are performed following linear
conversion of the above Fourier coeﬃcients to an alternative
set of polynomial coeﬃcients. While the images shown in
Figure 2 were obtained through linear ﬁtting on a per-pixel
basis for ease in visualization, the subsequent data analysis
presented herein involved linear ﬁtting after averaging the
polarization-dependent SHG response across each individual
crystal. The amplitudes of the Fourier coeﬃcients depend upon
both the inherent polarization-dependent SHG activity and the
orientation of each crystal within the ﬁeld of view. The inherent
polarization-dependent SHG activity for a crystal is described
by a rank 3 tensor, where each scalar entry describes the
eﬃciency and relative phase of frequency doubling given
deﬁned polarizations for both the incident and the exiting ﬁelds.
SHG expressed in the local Cartesian frame for the crystal can
yield as many as 18 unique nonzero tensor elements for a
material. However, many of these tensor elements are equal or
zero-valued by symmetry, with higher symmetry materials
containing more zero-valued and non-unique entries.
The ﬁrst method assessed for discrimination was based on
statistical analysis of the directly recovered Fourier coeﬃcients.

Figure 2. NOSE colormaps for two structures of D-mannitol. Values of
a−e from eq 1 are shown as a merged RGBCM image for each of two
photo detectors (horizontally and vertically polarized PMTs). The
values of a−e collectively describe all polarization-dependent nonlinear
optical properties of the sample, including the combined eﬀects of
both inherent polarization-dependent SHG activity and crystal
orientation within the ﬁeld of view.

and the vertically polarized PMT (V PMT). NOSE colormaps
are created through linear ﬁtting of the n-polarized SHG
intensities to a set of ﬁve Fourier coeﬃcients, as described
previously and shown in eq 1.

Figure 3. Histograms following two-class linear discriminant analysis of the raw polynomial coeﬃcients for orthorhombic (blue) and monoclinic
(red) forms of D-mannitol. The means of the recovered distributions fail a t test with >99.99% conﬁdence.
D
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Two-class linear discriminant analysis (LDA) was performed on
these coeﬃcients. These results are summarized in Figure 3.
Following projection onto the Fischer discriminant, histograms
of the pooled response from crystals of each structure were
constructed to visually compare separation of the probability
density functions (pdfs). The data were also compared via a
conventional F test and t test to quantitatively assess statistical
independence of the variances and means (respectively) of the
two experimental distributions. The t test was only performed if
the distributions ﬁrst pass the F test, indicating that the
variances in the compared data are not statistically distinguishable with 99.99% conﬁdence. Figure 3 shows a histogram of the
raw coeﬃcients following LDA for the orthorhombic (blue)
and monoclinic (red) structures. Calculated values for the F
and t tests are shown in Table 1, with green indicating a pass
and red indicating a failure of the test.

3 were intensity-normalized through division by the per-crystal
intensity values found via the iterative, nonlinear least-squares
ﬁtting algorithm. Figure 4a shows histograms of the projected
coeﬃcients after intensity-normalization. Additionally, histograms of these orientation-corrected intensity values are shown
directly in Figure 4b. Calculated F and t values are shown in
Table 1.
All statistical tests presented herein assume a 99.99%
conﬁdence interval. In brief, the recovered distributions
following LDA of the raw polynomial coeﬃcients pass the F
test but fail the t test, indicating that the pdfs giving rise to
these distributions have statistically independent means within
the 99.99% conﬁdence interval. The intensity-normalized
polynomial coeﬃcients pass both the F and the t tests (i.e.,
no statistically signiﬁcant discrimination at the given conﬁdence
interval can be achieved in either the variance or the mean
projected along the LDA axis). From inspection of the color
maps (Figure 2), it is clear that in-plane orientation of the
crystals contributes signiﬁcantly to the diversity of polarizationdependent responses observed in the laboratory frame.
To disentangle the eﬀects of laboratory-frame crystal
orientation from those of inherent local-frame polarization
dependence of the crystals, the above analyses were repeated
for the local-frame tensor elements obtained via the iterative,
nonlinear least-squares ﬁtting algorithm. These results are
summarized in Figures 5 and 6. Figure 5 shows histograms of
the raw local-frame tensor elements obtained for each crystal
structure, with the calculated F value shown in Table 1. The
orientation-corrected intensities obtained via nonlinear leastsquares analysis (Figure 4b) can also be included when
analyzing the distributions of the local-frame tensor elements.
For visualization purposes, a scatter plot showing the localframe tensor elements for each crystal form after multiplication
by the per-crystal intensities recovered via the iterative
nonlinear least-squares analysis is given in Figure 6a. The
larger variance of the monoclinic structures relative to the
orthorhombic structures is readily observed. Figure 6b shows a
histogram of the data in Figure 6a following LDA. The

Table 1. Summary of Statistical Testsa

a

Green shading indicates a pass, red shading indicates a failure.

Two diﬀerent contributions to the separation were
considered; changes in the polarization-dependence and
diﬀerences in the orientation-corrected, per-crystal SHG
intensities. The raw coeﬃcients giving rise to the histograms
shown in Figure 3 vary in response to changes in all of these
quantities. To aid in understanding the role of the orientationcorrected, per-crystal SHG intensities in driving the separation
of these distributions, the raw polynomial coeﬃcients in Figure

Figure 4. Histograms for the intensity-normalized polynomial coeﬃcients following LDA (A) and for the raw intensities obtained from the iterative
nonlinear least-squares ﬁtting algorithm (B). Distributions in (A) pass both the F test and the t test, while the distributions in (B) fail the F test.
These results are consistent with the orientation-corrected, per-crystal SHG intensities being the primary mechanism enabling discrimination of the
orthorhombic (blue) and monoclinic (red) crystal structures.
E
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Figure 5. Histograms of the raw local-frame tensor elements following LDA for orthorhombic (blue) and monoclinic (red) forms of D-mannitol. The
recovered distributions fail the F test with >99.99% conﬁdence.

Figure 6. Scatter plot (A) and histograms following LDA (B) of the intensity-corrected local frame tensor elements for orthorhombic (blue) and
monoclinic (red) forms of D-mannitol. The scatter plot in (A) allows direct visualization of the increased variance in the intensity-corrected localframe tenor elements observed for the monoclinic structures relative to orthorhombic structures. The distributions shown in (B) fail the F test.

calculated F value for the distributions shown in Figure 6b is
also included in Table 1. Both the local-frame tensor elements
and the intensity-corrected local-frame tensor elements fail the
F test, as summarized in Table 1.
Collectively, these tests yield information on the primary
mechanisms responsible for discrimination in NOSE microscopy measurements of crystal forms. The raw polynomial
coeﬃcients, which contain both intensity and polarization
information, pass the F test but fail the t test following LDA.
However, these data pass both the F and the t tests and are
statistically indistinguishable after removing the intensity
information from each set of polynomial coeﬃcients on a
per-crystal basis. When considering only orientation-corrected,

per-crystal SHG intensities and no polarization-dependent
information, the results from the two crystal forms fail the F
test, indicating statistically signiﬁcant discrimination. These
combined results are consistent with the disparity in
orientation-corrected, per-crystal SHG intensities between the
two samples serving as the primary discriminatory property
when laboratory-frame polynomial coeﬃcients are used for the
discrimination.
These results are also consistent with diverse crystal
orientations being the next most dominant mechanism
dictating the value of the polynomial coeﬃcients, suggesting
the potential for improved discrimination when using
orientation-corrected local-frame tensor elements instead of
F
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laboratory-frame polynomial coeﬃcients. Consistent with this
expectation, the calculated F values following LDA of the
derived local-frame tensor elements are signiﬁcantly higher
(eﬀectively inﬁnite discrimination) than those found following
LDA of the laboratory-frame polynomial coeﬃcients. These
results are consistent with increased separation observed
between the two structures once the orientation-dependence
of the nonlinear optical crystal response is removed. Fcalc for the
intensity-corrected local-frame tensor elements is greater than
Fcalc for the raw local-frame tensor elements. This increase
indicates that the discriminatory capability is further improved
when combining both the orientation-corrected per-crystal
SHG intensities and the local-frame polarization-dependence.
While orientation-corrected per-crystal SHG intensity
information alone may enable structure discrimination under
the experimental conditions in the present work, the conﬁdence
in that discrimination further improves when also considering
polarization-dependent eﬀects. Considering hypothetical NOSE
measurements with lower SNR than in the present study, it is
possible that discrimination could be enabled when considering
these combined observables, but not feasible when considering
only the orientation-corrected per-crystal SHG activities. It is
also worth noting that the scalar intensities found via the
nonlinear ﬁtting algorithm in the present study diﬀer from the
scalar intensity quantities in previous works. Scalar intensities
found through single-point measurements on bulk powdered
samples26−28 are sensitive not only to crystal polymorphic
form, but also to the presence or absence of phase matching,
the packing density, orientation distribution, and particle size
distribution of the sample. Several of these sources of ambiguity
have been addressed in more recent studies based on SHG
microscopy of powders.42 In contrast, the single-crystal,
orientation-corrected intensities presented here-in have largely
removed the dependence on packing density, orientation, and
phase-matching, further isolating the eﬀects from polymorphism on the overall SHG intensity.
While the recovery of local-frame tensor elements was
demonstrated for the P212121 and P21 crystal classes in this
work, this strategy can be generalized to other crystal classes.
With the exception of rare octahedral chiral symmetries, SHG is
bulk allowed in all chiral crystal structures. Discrimination of
crystals structures by NOSE should in theory be possible under
these same constraints. The general ability of NOSE for
discriminating speciﬁc crystal classes is highly dependent on the
diﬀerences in molecular packing and orientation relative to the
crystallographic coordinates, such that general conclusions
should be made cautiously. Fortunately, relatively simple
molecular-level calculations can provide reasonable estimates
regarding the discriminatory capability of NOSE. Previous work
has demonstrated good correspondence between ab initio
predictions and experimental orientationally averaged SHG
activities.43 It is reasonable to expect similar reliability for
prediction of the polarization-dependent diﬀerences between
unique crystal forms. The current experimental architecture
yields limits on the number of local-frame tensor elements
recoverable via the iterative nonlinear least-squares analysis.
However, the addition of a quarter wave plate to the beam path
(presample) and repetition of the data acquisition at multiple
wave-plate rotations could provide additional independent
measurements and enable the recovery of a higher number of
local-frame tensor elements.
The use of NOSE for polymorph discrimination oﬀers
several other advantages consistent with practical consider-

ations in performing HT crystallization studies for crystal form
discovery. While the polymorphs were synthesized at a relative
large (∼g) scale for ease of preparation, the actual microcrystalline mass used for discrimination is estimated to be
approximately 1 μg. This mass is consistent with per-well mass
values typically encountered in small-volume HT crystallization
studies. Additionally, NOSE imaging can be performed rapidly.
Each FOV in the present study took approximately 7 s to
acquire, although the observed SNR in the SHG images
(∼300) and high conﬁdence in the subsequent statistical tests
suggests this acquisition time could be signiﬁcantly reduced. In
any measurement, the limits of quantitation are always greater
than the limits of detection, including the present case. One of
the key enabling advantages of the NOSE measurement
approach is dramatic reduction in the 1/f noise relative to
analogous wave plate-based measurements, such that signiﬁcantly greater conﬁdence can be assigned with shorter
measurement times. NOSE imaging at video rates has been
demonstrated previously.31 Additionally, while the two
polymorphic forms were kept physically separated to ease
validation (e.g., PXRD) in this proof-of-concept study, the
analysis presented here (performed on a per-crystal basis) is
readily applicable to mixtures of polymorphic forms. Within the
assumption that the individual crystals within a multistructure
mixture could be prepared in a manner that minimizes physical
crystal overlap, the methodologies presented in this manuscript
should directly enable structure discrimination.
Finally, it is worth emphasizing that the discrimination
demonstrated in this study is based solely on the SHG
measurements alone. Additional considerations such as crystal
habit (e.g., needle, plate, etc.) could provide additional
complementary indicators for polymorphism discrimination
based on image analysis. Given that the SHG is expected to be
largely independent of crystal habit, the two methods should be
largely orthogonal. Although not the primary subject of the
present study, additional discrimination capabilities are possible
by combining the NOSE measurements with polarizationdependent laser transmittance microscopy, which is performed
concurrently with NOSE imaging. Bright ﬁeld imaging is
commonly used to identify crystal formation (hits) and crystal
structures/habits in HT studies; the laser transmittance images
obtained in NOSE retain this imaging modality. A sample laser
transmittance image for each crystal form is shown in the
Supporting Information (Figure SI-3). Furthermore, the
polarized detection present on this channel allows recovery of
observables describing sample birefringence, another modality
commonly used in the assessment of crystal forms in HT
studies. However, the polarization-dependent changes arising
from birefringence were generally relatively subtle compared to
analysis by NOSE and highly dependent on the thickness of the
crystals.
These collective results suggest the viability of NOSE for
rapid polymorph discrimination for fast prescreening. This ﬁrst
study was limited to the discrimination of two polymorphic
forms. In principle, extension to systems exhibiting many
accessible polymorphic forms simply represents expansion to nclass LDA. In practice, the high degree of discrimination
achieved from recovery of the local-frame tensor elements and
intensities suggests optimism in generalization of this approach
to higher numbers of crystal forms.
The recovery of crystal orientation angles also has the
potential to beneﬁt analysis of HT crystallizations by PXRD
and Raman. In the event that an outlier is detected based on
G
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NOSE microscopy as demonstrated herein, a natural next step
would be to conﬁrm or refute by an orthogonal method such as
PXRD or Raman. The limited number of crystals typically
found in modern solid form screens can complicate analysis by
both methods due to signiﬁcant preferred orientation eﬀects in
the observed scattering patterns.24,25 Accounting for these
eﬀects through increased data acquisition (e.g., repeating the
measurement at a variety of sample orientations) requires
signiﬁcant additional analysis times. The crystal orientation
information recovered through NOSE could potentially be fed
into these pipelines and used to correct for preferred
orientation eﬀects, helping to alleviate these additional
bottlenecks in crystal characterization. In this manner, NOSE
measurements may serve double-duty, ﬁrst for identiﬁcation of
outliers and next to aid in subsequent orthogonal analyses.

Amorphous Formulations Design through Quantitative Nonlinear Optical Analysis”; Grant No. 1412888-CHE. The authors
would also like to thank Ahmed Elkhabaz and the laboratory of
Professor Lynne S. Taylor (Department of Industrial and
Physical Pharmacy, Purdue University) for aid in acquisition of
PXRD patterns.

■

■

CONCLUSION
NOSE microscopy has been shown to allow highly conﬁdent
(>99.99%) discrimination of orthorhombic and monoclinic
crystal forms of D-mannitol in a few seconds of total
measurement time. Rapid (8 MHz) polarization modulation
allows the recovery of a set of polynomial coeﬃcients for each
sample at <7 s per FOV with a SNR of ∼300. These coeﬃcients
enabled discrimination directly, following two-class LDA for
dimension reduction. However, substantial improvements in
discrimination were achieved by correcting the polarizationdependent measurements for local crystal orientation. Transformation of the polarization-dependent response to the localframe allowed direct recovery of the tensor elements for the
P212121 crystal form and conﬁdent detection of the P21 crystals
that were not well described by those recovered local-frame
tensor elements. Furthermore, the complete analysis was
performed using only ∼1 μg of crystalline material. These
collective results have the potential to help address bottlenecks
in high-throughput crystallizations for therapeutic molecule
polymorph discovery.
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(14) Llinàs, A.; Goodman, J. M. Drug Discovery Today 2008, 13,
198−210.
(15) Almarsson, O.; Hickey, M. B.; Peterson, M. L.; Morissette, S. L.;
Soukasene, S.; McNulty, C.; Tawa, M.; MacPhee, J. M.; Remenar, J. F.
Cryst. Growth Des. 2003, 3, 927−933.
(16) Morissette, S. L.; Almarsson, O.; Peterson, M. L.; Remenar, J. F.;
Read, M. J.; Lemmo, A. V.; Ellis, S.; Cima, M. J.; Gardner, C. R. Adv.
Drug Delivery Rev. 2004, 56, 275−300.
(17) Peterson, M. L.; Morissette, S. L.; McNulty, C.; Goldsweig, A.;
Shaw, P.; LeQuesne, M.; Monagle, J.; Encina, N.; Marchionna, J.;
Johnson, A.; Gonzalez-Zugasti, J.; Lemmo, A. V.; Ellis, S. J.; Cima, M.
J.; Almarsson, O. J. Am. Chem. Soc. 2002, 124, 10958−10959.
(18) Lin, S.-Y. Pharm. Res. 2014, 31, 1619−1631.
(19) Lin, S.-Y.; Cheng, W.-T. J. Raman Spectrosc. 2012, 43, 1166−
1170.
(20) Kojima, T.; Onoue, S.; Murase, N.; Katoh, F.; Mano, T.;
Matsuda, Y. Pharm. Res. 2006, 23, 806−812.
(21) Heinz, A.; Savolainen, M.; Rades, T.; Strachan, C. J. Eur. J.
Pharm. Sci. 2007, 32, 182−192.
(22) Surwase, S. A.; Boetker, J. P.; Saville, D.; Boyd, B. J.; Gordon, K.
C.; Peltonen, L.; Strachan, C. J. Mol. Pharmaceutics 2013, 10, 4472−
4480.
(23) Detoisien, T.; Forite, M.; Taulelle, P.; Colson, D.; Klein, J. P.
Org. Process Res. Dev. 2009, 13, 1338−1342.
(24) Roberts, S. N. C.; Williams, A. C.; Grimsey, I. M.; Booth, S. W.
J. Pharm. Biomed. Anal. 2002, 28, 1149−1159.
(25) Roberts, S. N. C.; Williams, A. C.; Grimsey, I. M.; Booth, S. W.
J. Pharm. Biomed. Anal. 2002, 28, 1135−1147.
(26) Rawle, C. B.; Lee, C. J.; Strachan, C. J.; Payne, K.; Manson, P. J.;
Rades, T. J. Pharm. Sci. 2006, 95, 761−768.
(27) Strachan, C. J.; Rades, T.; Lee, C. J. Opt. Lasers Eng. 2005, 43,
209−220.
(28) Strachan, C. J.; Lee, C. J.; Rades, T. J. Pharm. Sci. 2004, 93,
733−742.

AUTHOR INFORMATION

Corresponding Author

*E-mail: gsimpson@purdue.edu.
Notes

The authors declare no competing ﬁnancial interest.

■

ACKNOWLEDGMENTS
We are grateful to the National Institute for Pharmaceutical
Technology and Education (NIPTE), the U.S. Food and Drug
Administration (FDA), and the National Science Foundation
(NSF) for providing funds for this research. This study was
funded by the FDA Grant to NIPTE titled “The Critical Path
Manufacturing Sector Research Initiative (U01)”; Grant No.
5U01FD004275, and the NSF GOALI award titled “Informing
H

DOI: 10.1021/acs.analchem.6b00057
Anal. Chem. XXXX, XXX, XXX−XXX

158
Article

Analytical Chemistry
(29) Lee, C. J.; Strachan, C. J.; Manson, P. J.; Rades, T. J. Pharm.
Pharmacol. 2007, 59, 241−250.
(30) Simon, F.; Clevers, S.; Dupray, V.; Coquerel, G. Chem. Eng.
Technol. 2015, 38, 971−983.
(31) DeWalt, E. L.; Sullivan, S. Z.; Schmitt, P. D.; Muir, R. D.;
Simpson, G. J. Anal. Chem. 2014, 86, 8448−8456.
(32) Dow, X. Y.; DeWalt, E. L.; Newman, J. A.; Dettmar, C. M.;
Simpson, G. J. Biophys. J. 2016, accepted for publication on April 21,
2016.
(33) Dow, X. Y.; DeWalt, E. L.; Sullivan, S. Z.; Schmitt, P. D.;
Ulcickas, J.; Simpson, G. J. Biophys. J. 2016, submitted for publication
on April 21, 2015.
(34) Kissick, D. J.; Wanapun, D.; Simpson, G. J. Annu. Rev. Anal.
Chem. 2011, 4, 419−437.
(35) Cornel, J.; Kidambi, P.; Mazzotti, M. Ind. Eng. Chem. Res. 2010,
49, 5854−5862.
(36) Berman, H. M.; Jeffrey, G. a.; Rosenstein, R. D. Acta Crystallogr.,
Sect. B: Struct. Crystallogr. Cryst. Chem. 1968, 24, 442−449.
(37) Kim, H. S.; Jeffrey, G. a.; Rosenstein, R. D. Acta Crystallogr., Sect.
B: Struct. Crystallogr. Cryst. Chem. 1968, 24, 1449−1455.
(38) Puspoki, Z.; Storath, M.; Sage, D.; Unser, M. Adv. Anat.,
Embryol. Cell Biol. 2016, in press.
(39) Rezakhaniha, R.; Agianniotis, A.; Schrauwen, J. T. C.; Griffa, A.;
Sage, D.; Bouten, C. V. C.; Van den Vosse, F. N.; Unser, M.;
Stergiopulos, N. Biomech. Model. Mechanobiol. 2012, 11, 461−473.
(40) Schneider, C. A.; Rasband, W. S.; Eliceiri, K. W. Nat. Methods
2012, 9, 671−675.
(41) Allen, F. H. Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 380−
388.
(42) Chowdhury, A. U.; Zhang, S.; Simpson, G. J. Anal. Chem. 2016,
88, 3853.
(43) Toth, S. J.; Schmitt, P. D.; Snyder, G. R.; Trasi, N. S.; Sullivan, S.
Z.; George, I. A.; Taylor, L. S.; Simpson, G. J. Cryst. Growth Des. 2015,
15, 581−586.

I

DOI: 10.1021/acs.analchem.6b00057
Anal. Chem. XXXX, XXX, XXX−XXX

